[X] Close
You are about to erase all the values you have customized, search history, page format, etc.
Click here to RESET all values       Click here to GO BACK without resetting any value
Items 1 to 100 of about 569
1. Xu ZL, Bethune D, Manos D, Foyle A, Henteleff H, Johnston M, Cartier Y: Pulmonary hyalinizing granuloma. Beijing Da Xue Xue Bao; 2009 Aug 18;41(4):463-8
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • In the second case, the patient presented with a 5.5 cm lung mass and a separate smaller lesion radiologically resembling bronchogenic carcinoma.
  • There was very prominent polyclonal lymphocytic proliferation at the periphery especially of the smaller lesion likely representing an early stage of the disease process.
  • In the third case, the patient presented with multiple subpleural plaque-like lesions in addition to nodular lesions of the lung.
  • CONCLUSION: Since patients with pulmonary hyalinizing granuloma demonstrated a spectrum of clinical presentations, radiologic changes and histologic features with a variety of associated clinical disorders, pulmonary hyalnizing granuloma is more in keeping with a clinicopathologic entity rather than a specific pathologic disease.
  • [MeSH-major] Granuloma, Respiratory Tract / pathology. Hyalin. Lung Diseases / pathology
  • [MeSH-minor] Adult. Diagnosis, Differential. Female. Humans. Male. Middle Aged. Tomography, X-Ray Computed

  • MedlinePlus Health Information. consumer health - Lung Diseases.
  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19727240.001).
  • [ISSN] 1671-167X
  • [Journal-full-title] Beijing da xue xue bao. Yi xue ban = Journal of Peking University. Health sciences
  • [ISO-abbreviation] Beijing Da Xue Xue Bao
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] China
  •  go-up   go-down


2. Paesmans M: [Evaluation criteria for bronchial carcinoma. How to read a meta-analysis?]. Rev Mal Respir; 2006 Nov;23(5 Pt 3):16S105-16S111
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Evaluation criteria for bronchial carcinoma. How to read a meta-analysis?].
  • [Transliterated title] Les critères d'évaluation des cancers broncho-pulmonaires. Comment lire une méta-analyse?
  • [MeSH-major] Carcinoma, Bronchogenic / diagnosis. Lung Neoplasms / diagnosis. Meta-Analysis as Topic

  • MedlinePlus Health Information. consumer health - Lung Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17268346.001).
  • [ISSN] 0761-8425
  • [Journal-full-title] Revue des maladies respiratoires
  • [ISO-abbreviation] Rev Mal Respir
  • [Language] fre
  • [Publication-type] English Abstract; Journal Article; Review
  • [Publication-country] France
  • [Number-of-references] 20
  •  go-up   go-down


3. Breitenbücher A, Chhajed PN, Brutsche MH, Mordasini C, Schilter D, Tamm M: Long-term follow-up and survival after Ultraflex stent insertion in the management of complex malignant airway stenoses. Respiration; 2008;75(4):443-9
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Long-term follow-up and survival after Ultraflex stent insertion in the management of complex malignant airway stenoses.
  • BACKGROUND: Despite being commercially available for a few years now, the literature regarding the outcome of Ultraflex stent insertion in complex malignant airway stenoses is sparse.
  • OBJECTIVES: To assess long-term complications and survival in patients with complex malignant airway stenoses treated with insertion of nitinol stents.
  • METHODS: 60 consecutive patients with Ultraflex stent insertion for malignant airway stenoses were included.
  • Diagnoses were bronchial carcinoma (n = 50), esophageal carcinoma (n = 3) and metastases (n = 7).
  • Stents were inserted in the trachea (n = 5), main bronchi/intermediate bronchus (n = 22), from main bronchi/intermediate bronchus to lobar bronchi (n = 28) or in the lobar bronchi themselves (n = 7).
  • Death (n = 59, 98%) was attributed mainly to disease progression with cachexia and metastases, pneumonia (n = 5, 10%), and hemoptysis (n = 1, 2%).
  • CONCLUSION: Ultraflex stents have a low complication rate and can be effectively used in complex malignant airway stenoses with marked asymmetry or irregularity, angulation or changing diameters.
  • [MeSH-minor] Adult. Aged. Alloys. Bronchial Neoplasms / complications. Carcinoma / complications. Constriction, Pathologic / etiology. Constriction, Pathologic / therapy. Female. Humans. Male. Middle Aged. Retrospective Studies. Survival Analysis

  • MedlinePlus Health Information. consumer health - Choking.
  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] (c) 2008 S. Karger AG, Basel.
  • (PMID = 18477862.001).
  • [ISSN] 1423-0356
  • [Journal-full-title] Respiration; international review of thoracic diseases
  • [ISO-abbreviation] Respiration
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] Switzerland
  • [Chemical-registry-number] 0 / Alloys; 52013-44-2 / nitinol
  •  go-up   go-down


Advertisement
4. Takahashi M, Murakami Y, Nitta N, Murata K, Tezuka N, Fujino S, Okabe H: Pulmonary infarction associated with bronchogenic carcinoma. Radiat Med; 2008 Feb;26(2):76-80
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Pulmonary infarction associated with bronchogenic carcinoma.
  • Computed tomography findings of pathologically proven pulmonary infarction associated with bronchogenic carcinoma are reported for two patients.
  • We conclude that pulmonary infarction should be considered as a differential diagnosis when peripheral pulmonary nodules or masses are located in the same lobe as the primary cancer.
  • [MeSH-major] Adenocarcinoma / diagnosis. Carcinoma, Bronchogenic / diagnosis. Carcinoma, Small Cell / diagnosis. Lung Neoplasms / diagnosis. Pulmonary Infarction / diagnosis
  • [MeSH-minor] Contrast Media / administration & dosage. Diagnosis, Differential. Humans. Incidental Findings. Lung / diagnostic imaging. Lung / surgery. Male. Middle Aged. Radiographic Image Enhancement / methods. Tomography, X-Ray Computed

  • MedlinePlus Health Information. consumer health - Lung Cancer.
  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Nihon Kyobu Shikkan Gakkai Zasshi. 1995 Oct;33(10 ):1064-72 [8544377.001]
  • [Cites] Radiology. 1982 Dec;145(3):593-7 [7146385.001]
  • [Cites] N Engl J Med. 1977 Jun 23;296(25):1431-5 [865513.001]
  • [Cites] Ann Thorac Cardiovasc Surg. 2006 Jun;12 (3):189-93 [16823332.001]
  • [Cites] Am J Med. 1982 Apr;72(4):599-606 [6462058.001]
  • [Cites] Am J Roentgenol Radium Ther Nucl Med. 1974 Jan;120(1):145-50 [4810291.001]
  • [Cites] Surgery. 1952 Feb;31(2):167-79 [14913425.001]
  • [Cites] Nihon Igaku Hoshasen Gakkai Zasshi. 1989 Sep 25;49(9):1112-21 [2587194.001]
  • [Cites] J Comput Assist Tomogr. 1989 Nov-Dec;13(6):941-5 [2584503.001]
  • [Cites] Thorax. 1954 Dec;9(4):304-12 [13226312.001]
  • [Cites] Jpn J Clin Oncol. 2000 Jan;30(1):40-2 [10770569.001]
  • (PMID = 18301982.001).
  • [ISSN] 0288-2043
  • [Journal-full-title] Radiation medicine
  • [ISO-abbreviation] Radiat Med
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] Japan
  • [Chemical-registry-number] 0 / Contrast Media
  •  go-up   go-down


5. Faber J, Pierard P, Prigogine T, Dusart M, Haller A, Bosschaerts T, Sculier JP, Ninane V: [Endobronchial ultrasound and PET positive mediastinal lymph nodes]. Rev Mal Respir; 2006 Feb;23(1 Pt 1):37-42
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Transliterated title] Echographie endobronchique et ganglions TEP positifs dans le cancer broncho-pulmonaire.
  • INTRODUCTION: In bronchial carcinoma when positron emission tomography with 18-fluorodeoxyglucose (FDG-PET) shows increased emission in the mediastinal lymph nodes, confirmation by tissue biopsy is necessary.
  • METHODS: Consecutive patients referred for staging and/or diagnosis of PET positive mediastinal nodes in the setting of suspected or confirmed bronchial carcinoma were included.
  • CONCLUSION: Endobronchial ultrasound with needle aspiration should be considered a primary method of investigation of PET positive mediastinal lymph nodes.
  • [MeSH-major] Lung Neoplasms / radionuclide imaging. Lung Neoplasms / ultrasonography. Positron-Emission Tomography
  • [MeSH-minor] Biopsy, Needle. Bronchi / ultrasonography. Female. Humans. Lymphatic Metastasis. Male. Mediastinum. Middle Aged. Prospective Studies

  • MedlinePlus Health Information. consumer health - Lung Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [CommentIn] Rev Mal Respir. 2006 Feb;23(1 Pt 1):13-5 [16604019.001]
  • (PMID = 16604024.001).
  • [ISSN] 0761-8425
  • [Journal-full-title] Revue des maladies respiratoires
  • [ISO-abbreviation] Rev Mal Respir
  • [Language] fre
  • [Publication-type] English Abstract; Journal Article
  • [Publication-country] France
  •  go-up   go-down


6. Merrilees MJ, Ching PS, Beaumont B, Hinek A, Wight TN, Black PN: Changes in elastin, elastin binding protein and versican in alveoli in chronic obstructive pulmonary disease. Respir Res; 2008;9:41
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Changes in elastin, elastin binding protein and versican in alveoli in chronic obstructive pulmonary disease.
  • METHODS: Lung samples were obtained from 26 control (FEV1 > or = 80% predicted, FEV1/VC >0.7) and 17 COPD patients (FEV1 > or = 40% - <80% predicted, FEV1/VC < or = 0.7) who had undergone a lobectomy for bronchial carcinoma.
  • [MeSH-major] Elastin / metabolism. Pulmonary Alveoli / metabolism. Pulmonary Disease, Chronic Obstructive / metabolism. Receptors, Cell Surface / metabolism. Versicans / metabolism

  • Genetic Alliance. consumer health - Pulmonary Disease.
  • Genetic Alliance. consumer health - Chronic obstructive pulmonary disease.
  • MedlinePlus Health Information. consumer health - COPD.
  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Am J Pathol. 2004 Jan;164(1):119-31 [14695326.001]
  • [Cites] Crit Rev Oncol Hematol. 2004 Mar;49(3):199-202 [15036260.001]
  • [Cites] J Pathol. 2004 Jun;203(2):653-60 [15141380.001]
  • [Cites] Am Rev Respir Dis. 1967 Apr;95(4):623-30 [6021123.001]
  • [Cites] J Clin Invest. 1993 Mar;91(3):1198-205 [8383699.001]
  • [Cites] Am Rev Respir Dis. 1993 Apr;147(4):975-81 [8466136.001]
  • [Cites] J Cell Biol. 1994 Jul;126(2):563-74 [8034752.001]
  • [Cites] Cell Adhes Commun. 1994 Jul;2(3):185-93 [7827955.001]
  • [Cites] Biol Chem. 1996 Jul-Aug;377(7-8):471-80 [8922281.001]
  • [Cites] Am J Respir Crit Care Med. 1996 Dec;154(6 Pt 1):1819-28 [8970376.001]
  • [Cites] Am J Respir Crit Care Med. 1997 Jul;156(1):240-7 [9230755.001]
  • [Cites] Eur Respir J. 1997 Dec;10(12):2731-7 [9493652.001]
  • [Cites] J Biol Chem. 1998 Mar 13;273(11):6319-26 [9497360.001]
  • [Cites] Am J Respir Crit Care Med. 1998 Aug;158(2):555-64 [9700135.001]
  • [Cites] Lab Invest. 1998 Sep;78(9):1077-87 [9759652.001]
  • [Cites] Arterioscler Thromb Vasc Biol. 1999 Jul;19(7):1630-9 [10397680.001]
  • [Cites] Mod Pathol. 1999 Jul;12(7):697-705 [10430274.001]
  • [Cites] Am J Respir Crit Care Med. 1999 Aug;160(2):725-9 [10430752.001]
  • [Cites] Am J Pathol. 1961 Sep;39:355-67 [13786819.001]
  • [Cites] J Biol Chem. 2006 Feb 10;281(6):3698-710 [16314420.001]
  • [Cites] Circ Res. 2006 Feb 17;98(3):370-7 [16385080.001]
  • [Cites] Am J Physiol Regul Integr Comp Physiol. 2007 Aug;293(2):R784-92 [17522116.001]
  • [Cites] Am J Respir Cell Mol Biol. 2008 May;38(5):509-16 [18063838.001]
  • [Cites] Respir Med. 2003 Jun;97(6):634-9 [12814147.001]
  • [Cites] Circ Res. 2002 Mar 8;90(4):481-7 [11884379.001]
  • [Cites] Coron Artery Dis. 2001 Feb;12(1):7-16 [11211169.001]
  • [Cites] Int Arch Allergy Immunol. 2000 Nov;123(3):259-67 [11112863.001]
  • [Cites] Chest. 2000 Mar;117(3):684-94 [10712992.001]
  • [Cites] Am J Hum Genet. 2000 Mar;66(3):859-72 [10712202.001]
  • [Cites] Am J Pathol. 2000 Mar;156(3):925-38 [10702409.001]
  • [Cites] Exp Cell Res. 1992 Dec;203(2):344-53 [1333980.001]
  • [Cites] Am Rev Respir Dis. 1992 Dec;146(6):1615-22 [1456587.001]
  • [Cites] J Clin Invest. 1991 Dec;88(6):2083-94 [1661296.001]
  • [Cites] Eur Respir J. 2008 May;31(5):998-1004 [18216063.001]
  • [Cites] Hum Pathol. 1989 Jul;20(7):652-9 [2661409.001]
  • [Cites] J Cell Biol. 1991 Apr;113(1):187-94 [1848864.001]
  • [Cites] Hum Pathol. 1977 Nov;8(6):669-77 [562833.001]
  • [Cites] Am J Med. 1980 Sep;69(3):351-9 [7416182.001]
  • [Cites] Anat Rec. 1981 Nov;201(3):523-35 [6914132.001]
  • [Cites] Am Rev Respir Dis. 1982 Jan;125(1):85-8 [6175261.001]
  • [Cites] Am J Anat. 1983 Aug;167(4):405-39 [6624688.001]
  • [Cites] Connect Tissue Res. 1985;13(2):169-79 [3157544.001]
  • [Cites] Am Rev Respir Dis. 1985 Sep;132(3):640-3 [3929658.001]
  • [Cites] Am Rev Respir Dis. 1986 Jan;133(1):149-69 [3510579.001]
  • [Cites] Connect Tissue Res. 1987;16(3):237-57 [2956051.001]
  • [Cites] Science. 1988 Mar 25;239(4847):1539-41 [2832941.001]
  • (PMID = 18485243.001).
  • [ISSN] 1465-993X
  • [Journal-full-title] Respiratory research
  • [ISO-abbreviation] Respir. Res.
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] England
  • [Chemical-registry-number] 0 / Receptors, Cell Surface; 0 / elastin-binding proteins; 126968-45-4 / Versicans; 9007-58-3 / Elastin
  • [Other-IDs] NLM/ PMC2397404
  •  go-up   go-down


7. Cooper L, Hagenschneider JK, Banky S, Rosado-de-Christenson ML, Suster S: Papillary endobronchial squamous cell carcinoma. Ann Diagn Pathol; 2005 Oct;9(5):284-8
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Papillary endobronchial squamous cell carcinoma.
  • A case of papillary endobronchial squamous cell carcinoma incidentally discovered on routine imaging studies is described.
  • Computed tomography of the chest, however, demonstrated an elongated, irregular mass in the right lower lobe that appeared to be associated with an adjacent segmental right lower lobe bronchus.
  • Endoscopy followed by surgical resection was undertaken, revealing a tan, soft mass measuring 1.5 x 1.3 x 0.8 cm that was confined to the bronchus and did not appear to extend into the surrounding lung parenchyma.
  • Microscopically, the mass showed a papillary, superficial squamous cell carcinoma confined to the bronchial mucosa without invasion of adjacent structures.
  • The pathological and imaging features of this unusual variant of bronchogenic carcinoma are reviewed as well as the radiological differential diagnosis of endobronchial lesions.
  • [MeSH-major] Carcinoma, Bronchogenic / pathology. Carcinoma, Bronchogenic / radiography. Carcinoma, Squamous Cell / pathology. Carcinoma, Squamous Cell / radiography. Lung Neoplasms / pathology. Lung Neoplasms / radiography
  • [MeSH-minor] Aged. Carcinoma, Papillary / pathology. Diagnosis, Differential. Female. Hip Fractures / complications. Humans. Tomography, X-Ray Computed

  • Genetic Alliance. consumer health - Carcinoma, Squamous Cell.
  • MedlinePlus Health Information. consumer health - Lung Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16198957.001).
  • [ISSN] 1092-9134
  • [Journal-full-title] Annals of diagnostic pathology
  • [ISO-abbreviation] Ann Diagn Pathol
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] United States
  •  go-up   go-down


8. Saranović DjZ, Djurić-Stefanović A, Ivanović AM, Masulović DM, Lazić LjR, Marković ZR, Pesko PM: [Solving of complications arising during and after application self-expandible metallic stents in palliation of malignant dysphagia]. Acta Chir Iugosl; 2009;56(4):91-7
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Solving of complications arising during and after application self-expandible metallic stents in palliation of malignant dysphagia].
  • INTRODUCTION: During palliative treatment of malignant disphagia in inoperabile patients various and serious complications may occur and compromite the method of treatment if there were not solved.
  • MATERIALS AND METHOD: From 1996. to 2009. in 237 patients (164 esophageal carcinoma, 33 carcinoma of the esophagogastric junction, 14 bronchial carcinoma, 7 esophagojejunal anastomosis, 9 esophageal fistulas) 245 stents have been placed (54 uncovered and 191 covered).
  • Esophageal perforation (1), stent migration (9), malignant tissue ingrowth (31) and overgrowth (24) have been revealed by barium contrast study during follow up.

  • Genetic Alliance. consumer health - Dysphagia.
  • MedlinePlus Health Information. consumer health - Palliative Care.
  • MedlinePlus Health Information. consumer health - Swallowing Disorders.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 20420003.001).
  • [ISSN] 0354-950X
  • [Journal-full-title] Acta chirurgica Iugoslavica
  • [ISO-abbreviation] Acta Chir Iugosl
  • [Language] srp
  • [Publication-type] English Abstract; Journal Article
  • [Publication-country] Serbia
  •  go-up   go-down


9. Merget R, Johnen G, Pesch B, Brüning T: [Lung cancer screening revisited -- are we merely combing a giraffe?]. Pneumologie; 2005 Mar;59(3):165-6
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Lung cancer screening revisited -- are we merely combing a giraffe?].
  • [Transliterated title] Bronchialkarzinom-Screening.
  • [MeSH-major] Lung Neoplasms / diagnosis. Mass Screening / standards


10. Escarguel B, D'Amore D, Chapel F, Bec J, Audigier-Valette C, Lahlah H, Milhe F, Marqueste L: [Early diagnosis of lung cancer: impact of autofluorescence bronchoscopy]. Rev Pneumol Clin; 2009 Oct;65(5):287-91
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Early diagnosis of lung cancer: impact of autofluorescence bronchoscopy].
  • [Transliterated title] Diagnostic précoce du cancer bronchique : apport de la bronchoscopie en autofluorescence.
  • INTRODUCTION: Less than 15% of all patients survive five years after a diagnosis of lung cancer.
  • Among the methods of early diagnosis of bronchial cancer, autofluorescence bronchoscopy allows for the early identification of preinvasive bronchial lesions.
  • An histological abnormality was found in 76% of the samples, with 34 hyperplasia (28%), 56 squamous metaplasia (46%), three mild dysplasia (3%), two moderate dysplasia (2%), one severe dysplasia (1%), two carcinomas in situ (2%) and 21 invasive carcinomas (18%).
  • CONCLUSION: Autofluorescence bronchoscopy is an effective examination for the detection of the preinvasive neoplasic lesions and may be proposed when lung cancer is suspected.
  • [MeSH-major] Bronchoscopy / methods. Carcinoma in Situ / diagnosis. Carcinoma, Squamous Cell / diagnosis. Fluorescence. Lung Neoplasms / diagnosis
  • [MeSH-minor] Aged. Biopsy. Early Diagnosis. Female. Humans. Hyperplasia / diagnosis. Lung / pathology. Male. Metaplasia / diagnosis. Middle Aged. Precancerous Conditions / diagnosis. Predictive Value of Tests. Prognosis. Prospective Studies. Risk Factors. Sensitivity and Specificity. Smoking / adverse effects

  • Genetic Alliance. consumer health - Lung Cancer.
  • MedlinePlus Health Information. consumer health - Lung Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19878802.001).
  • [ISSN] 0761-8417
  • [Journal-full-title] Revue de pneumologie clinique
  • [ISO-abbreviation] Rev Pneumol Clin
  • [Language] fre
  • [Publication-type] English Abstract; Journal Article
  • [Publication-country] France
  •  go-up   go-down


11. Blanchon F, Grivaux M, Zureik M, Marsal L, Asselain B, Lebas FX, Orlando JP, Steenhouwer F, Benichou-Flurin M, Coëtmeur D, Collon T, David P, Delclaux B, Piquet J: [Cohort KBP-2000-CPHG: Evaluation of factors influencing survival in lung cancer]. Rev Mal Respir; 2006 Apr;23(2 Pt 1):165-71
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Cohort KBP-2000-CPHG: Evaluation of factors influencing survival in lung cancer].
  • [Transliterated title] Cohorte KBP-2000-CPHG: évaluation des facteurs pronostiques de la survie du cancer bronchique primitif à 2 et 5 ans.
  • INTRODUCTION: Lung cancer continues to have a poor prognosis despite some therapeutic advances.
  • BACKGROUND: The last fifteen years has seen a dramatic increase in the incidence of lung cancer in women and an increased proportion of adenocarcinomas in both sexes.
  • METHODS: KBP-2000-CPHG is an epidemiological study carried out throughout the year 2000 looking at histologically confirmed primary lung cancers managed in general hospitals.
  • [MeSH-major] Lung Neoplasms / mortality
  • [MeSH-minor] Adenocarcinoma / mortality. Adenocarcinoma / pathology. Adult. Age Distribution. Aged. Carcinoma, Large Cell / mortality. Carcinoma, Large Cell / pathology. Carcinoma, Non-Small-Cell Lung / mortality. Carcinoma, Non-Small-Cell Lung / pathology. Carcinoma, Small Cell / mortality. Carcinoma, Small Cell / pathology. Carcinoma, Squamous Cell / mortality. Carcinoma, Squamous Cell / pathology. Cause of Death. Cohort Studies. Female. Follow-Up Studies. France / epidemiology. Hospitals, General / statistics & numerical data. Humans. Middle Aged. Neoplasm Staging. Prognosis. Sex Distribution. Smoking / adverse effects. Smoking / epidemiology. Socioeconomic Factors. Survival Analysis

  • Genetic Alliance. consumer health - Lung Cancer.
  • MedlinePlus Health Information. consumer health - Lung Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [CommentIn] Rev Mal Respir. 2006 Apr;23(2 Pt 1):115-6 [16788434.001]
  • (PMID = 16788443.001).
  • [ISSN] 0761-8425
  • [Journal-full-title] Revue des maladies respiratoires
  • [ISO-abbreviation] Rev Mal Respir
  • [Language] fre
  • [Publication-type] English Abstract; Journal Article; Multicenter Study
  • [Publication-country] France
  •  go-up   go-down


12. Freixinet JL, Julià-Serdà G, Rodríguez PM, Santana NB, de Castro FR, Fiuza MD, López-Encuentra A, Bronchogenic Carcinoma Cooperative Group of the Spanish Society of Pneumology and Thoracic Surgery GCCB-S: Hospital volume: operative morbidity, mortality and survival in thoracotomy for lung cancer. A Spanish multicenter study of 2994 cases. Eur J Cardiothorac Surg; 2006 Jan;29(1):20-5
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Hospital volume: operative morbidity, mortality and survival in thoracotomy for lung cancer. A Spanish multicenter study of 2994 cases.
  • OBJECTIVE: To determine the relationship between the number of interventions and the operative morbidity, mortality and long-term survival in the surgery of bronchogenic carcinoma (BC).
  • PATIENTS AND METHOD: Prospective, multicenter Spanish study was conducted in 19 departments of thoracic surgery on 2994 patients operated on consecutively with the aim of curing BC.
  • [MeSH-major] Carcinoma, Bronchogenic / epidemiology. Lung Neoplasms / epidemiology. Thoracotomy / mortality

  • Genetic Alliance. consumer health - Lung Cancer.
  • MedlinePlus Health Information. consumer health - Lung Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16343923.001).
  • [ISSN] 1010-7940
  • [Journal-full-title] European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery
  • [ISO-abbreviation] Eur J Cardiothorac Surg
  • [Language] eng
  • [Publication-type] Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't
  • [Publication-country] Germany
  •  go-up   go-down


13. Klein F: [Non-small cell lung neoplasms--weekly taxane combinations are possible]. Pneumologie; 2007 Dec;61(12):755
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Non-small cell lung neoplasms--weekly taxane combinations are possible].
  • [Transliterated title] Nicht kleinzelliges Bronchialkarzinom - Taxankombination wöchentlich möglich.
  • [MeSH-major] Antineoplastic Combined Chemotherapy Protocols / administration & dosage. Carcinoma, Non-Small-Cell Lung / drug therapy. Clinical Trials as Topic. Lung Neoplasms / drug therapy

  • MedlinePlus Health Information. consumer health - Clinical Trials.
  • MedlinePlus Health Information. consumer health - Lung Cancer.
  • Hazardous Substances Data Bank. TAXOL .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18275018.001).
  • [ISSN] 1438-8790
  • [Journal-full-title] Pneumologie (Stuttgart, Germany)
  • [ISO-abbreviation] Pneumologie
  • [Language] ger
  • [Publication-type] Journal Article
  • [Publication-country] Germany
  • [Chemical-registry-number] 0W860991D6 / Deoxycytidine; B76N6SBZ8R / gemcitabine; P88XT4IS4D / Paclitaxel
  •  go-up   go-down


14. Gibson TN, Hanchard B, Waugh N, McNaughton D: Age-specific incidence of cancer in Kingston and St. Andrew, Jamaica, 2003-2007. West Indian Med J; 2010 Oct;59(5):456-64
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Age-specific incidence of cancer in Kingston and St. Andrew, Jamaica, 2003-2007.
  • In males, the leading sites for cancer were prostate, bronchus and large bowel, while in females, they were breast, cervix uteri and large bowel.
  • The leading sites for both genders have been maintained in the same order as in the previous report, but for males, there were increases in the incidence of prostate (ASR 65.5 vs. 78.1 per 100,000 per year) and colorectal (ASR 13.7 vs. 17.2 per 100,000 per year) cancers and a decrease in the incidence of cancer of the bronchus (ASR 22.8 vs. 18.6 per 100,000 per year).
  • For females, there was a modest decrease in incidence of cervical cancer (ASR 19 vs. 17.4 per 100,000 per year) while the incidence of cancers of the breast and large bowel remained relatively stable (ASR 40.1 vs. 43 per 100,000 per year for breast and ASR 13 vs. 12.8 per 100,000 per year for colorectal cancer).
  • Malignancies of unknown primary site were common in both genders and require further investigation.

  • MedlinePlus Health Information. consumer health - Cancer in Children.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 21473389.001).
  • [ISSN] 0043-3144
  • [Journal-full-title] The West Indian medical journal
  • [ISO-abbreviation] West Indian Med J
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] Jamaica
  •  go-up   go-down


15. Chouahnia K, Brechot JM, Des-Guetz G, Saintigny P, Morere JF, Breau JL: [Gefitinib treatment for carcinomatous meningitis in non-small cell lung cancer]. Rev Mal Respir; 2006 Apr;23(2 Pt 1):149-51
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Gefitinib treatment for carcinomatous meningitis in non-small cell lung cancer].
  • [Transliterated title] Géfitinib et méningite carcinomateuse d'un carcinome bronchique non à petites cellules (CBNPC).
  • BACKGROUND: Carcinomatous meningitis is a major complication in Non Small Cell Lung Cancer (NSCLC).
  • OBSERVATION: We report a case of a female non-smoker with adenocarcinoma with bronchoalveolar features presenting with carcinomatous meningitis three years after the diagnosis of her primary tumour.
  • [MeSH-major] Adenocarcinoma, Bronchiolo-Alveolar / drug therapy. Antineoplastic Agents / therapeutic use. Carcinoma, Non-Small-Cell Lung / drug therapy. Chemotherapy, Adjuvant. Lung Neoplasms / pathology. Meningitis / drug therapy. Protein Kinase Inhibitors / therapeutic use. Quinazolines / therapeutic use
  • [MeSH-minor] Carboplatin / administration & dosage. Cisplatin / administration & dosage. Combined Modality Therapy. Cranial Irradiation. Female. Humans. Middle Aged. Neoplasm Proteins / antagonists & inhibitors. Paclitaxel / administration & dosage. Palliative Care. Pneumonectomy. Receptor, Epidermal Growth Factor / antagonists & inhibitors. Vinblastine / administration & dosage. Vinblastine / analogs & derivatives

  • Genetic Alliance. consumer health - Lung Cancer.
  • Genetic Alliance. consumer health - Non-small cell lung cancer.
  • MedlinePlus Health Information. consumer health - Cancer Chemotherapy.
  • MedlinePlus Health Information. consumer health - Lung Cancer.
  • MedlinePlus Health Information. consumer health - Meningitis.
  • Hazardous Substances Data Bank. CIS-DIAMINEDICHLOROPLATINUM .
  • Hazardous Substances Data Bank. TAXOL .
  • Hazardous Substances Data Bank. CARBOPLATIN .
  • Hazardous Substances Data Bank. VINORELBINE .
  • Hazardous Substances Data Bank. VINBLASTINE .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16788439.001).
  • [ISSN] 0761-8425
  • [Journal-full-title] Revue des maladies respiratoires
  • [ISO-abbreviation] Rev Mal Respir
  • [Language] fre
  • [Publication-type] Case Reports; English Abstract; Journal Article
  • [Publication-country] France
  • [Chemical-registry-number] 0 / Antineoplastic Agents; 0 / Neoplasm Proteins; 0 / Protein Kinase Inhibitors; 0 / Quinazolines; 5V9KLZ54CY / Vinblastine; BG3F62OND5 / Carboplatin; EC 2.7.10.1 / Receptor, Epidermal Growth Factor; P88XT4IS4D / Paclitaxel; Q20Q21Q62J / Cisplatin; Q6C979R91Y / vinorelbine; S65743JHBS / gefitinib
  •  go-up   go-down


16. Schmidt B, Liebers U, Witt C: [Screening for bronchial carcinoma -- pro]. Dtsch Med Wochenschr; 2005 Mar 4;130(9):466
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Screening for bronchial carcinoma -- pro].
  • [Transliterated title] Screeningprogramme für das Bronchialkarzinom -- Pro.
  • [MeSH-major] Carcinoma, Bronchogenic / diagnosis. Lung Neoplasms / diagnosis. Mass Screening

  • MedlinePlus Health Information. consumer health - Lung Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 15731960.001).
  • [ISSN] 0012-0472
  • [Journal-full-title] Deutsche medizinische Wochenschrift (1946)
  • [ISO-abbreviation] Dtsch. Med. Wochenschr.
  • [Language] ger
  • [Publication-type] Journal Article
  • [Publication-country] Germany
  •  go-up   go-down


17. Wang KP, Browning R: Transbronchial needle aspiration with or without endobronchial ultrasound. Thorac Cancer; 2010 Jul;1(2):87-93
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Transbronchial needle aspiration (TBNA) has been used for over three decades in the diagnosis and staging of mediastinal adenopathy and masses.
  • Eduardo Schieppati, this rigid bronchoscope technique received very little attention until 1978 at Johns Hopkins Hospital where Wang and colleagues described in detail the diagnosis of a paratracheal mass by TBNA biopsy through a rigid bronchoscope using a 25-gauge esophageal variceal needle.
  • In 1983, a novel flexible needle that could be used with the flexible bronchoscope to perform TBNA was developed and introduced for diagnosis and staging of bronchogenic carcinoma.
  • Immediately to follow was the expansion of its use in the diagnosis of peripheral pulmonary nodules and benign mediastinum and hilar disorders by obtaining histological core specimens.
  • Whether this will enhance the result of TBNA and spread the TBNA technique as a standard lung cancer staging procedure is yet to be seen.
  • Its future relies on a hybrid instrument and methodology to be widely applied to the diagnosis and staging of bronchogenic carcinoma.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] © Tianjin Lung Cancer Institute and Blackwell Publishing Asia Pty. Ltd.
  • (PMID = 27755777.001).
  • [ISSN] 1759-7714
  • [Journal-full-title] Thoracic cancer
  • [ISO-abbreviation] Thorac Cancer
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] Singapore
  • [Keywords] NOTNLM ; Bronchoscopy / EBUS / transbronchial needle aspiration
  •  go-up   go-down


18. Guarnaschelli JN, Jose BO: Palliative high-dose-rate endobronchial brachytherapy for recurrent carcinoma: the University of Louisville experience. J Palliat Med; 2010 Aug;13(8):981-9
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Palliative high-dose-rate endobronchial brachytherapy for recurrent carcinoma: the University of Louisville experience.
  • PURPOSE: To determine the efficacy and toxicity of iridium-192 high-dose-rate (HDR) endobronchial brachytherapy (EBBT) for symptomatic palliation of respiratory symptoms caused by endobronchial carcinoma.
  • METHODS: We reviewed the treatment outcomes of 52 patients with carcinoma who underwent HDR EBBT between July 1995 and July 2005 for recurrent tumors at the University of Louisville School of Medicine.
  • CONCLUSIONS: The results confirm the efficacy of endobronchial brachytherapy in relieving obstructive airway symptoms from endoluminal bronchogenic carcinomas.
  • [MeSH-major] Brachytherapy / methods. Carcinoma, Bronchogenic / radiotherapy. Iridium Radioisotopes / therapeutic use. Lung Neoplasms / radiotherapy. Neoplasm Recurrence, Local / radiotherapy. Palliative Care / methods

  • MedlinePlus Health Information. consumer health - Lung Cancer.
  • MedlinePlus Health Information. consumer health - Palliative Care.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 20666622.001).
  • [ISSN] 1557-7740
  • [Journal-full-title] Journal of palliative medicine
  • [ISO-abbreviation] J Palliat Med
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Iridium Radioisotopes
  •  go-up   go-down


19. Gaissert HA, Grillo HC, Shadmehr MB, Wright CD, Gokhale M, Wain JC, Mathisen DJ: Uncommon primary tracheal tumors. Ann Thorac Surg; 2006 Jul;82(1):268-72; discussion 272-3
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Uncommon primary tracheal tumors.
  • BACKGROUND: Primary tracheal tumors other than adenoid cystic or squamous cell carcinoma are uncommon and have a heterogeneous histologic appearance.
  • METHODS: A retrospective analysis was performed of uncommon tracheal tumors among 360 primary tracheal tumors seen over 40 years, excluding adenoid cystic and squamous cell carcinoma.
  • RESULTS: Of 90 patients, 34 (38%) had benign tumors and 56 malignant: 11 carcinoid tumors, 14 mucoepidermoid carcinomas, 13 sarcomas, 15 nonsquamous bronchogenic carcinomas, 2 lymphomas, and 1 melanoma.
  • Dyspnea was the most common symptom in benign tumors and hemoptysis in malignant tumors.
  • After resection, survival at 10 years was 94% for benign and 83% for carcinoid tumors, and at 5 years survival was 60% for bronchogenic carcinoma, 100% for mucoepidermoid tumors, and 78% for sarcomas.
  • CONCLUSIONS: Surgical resection of uncommon primary tracheal tumors alleviates airway obstruction, is curative in patients with benign or slow-growing malignant lesions, and prolongs survival in highly malignant lesions.
  • [MeSH-minor] Adolescent. Adult. Aged. Aged, 80 and over. Bronchi / surgery. Bronchoscopy. Child. Child, Preschool. Combined Modality Therapy. Female. Follow-Up Studies. Hospital Mortality. Humans. Laryngeal Neoplasms / epidemiology. Laryngeal Neoplasms / pathology. Laryngeal Neoplasms / surgery. Laryngectomy. Life Tables. Male. Middle Aged. Neoplasm Metastasis. Neoplasm Recurrence, Local / epidemiology. Postoperative Complications / epidemiology. Radiotherapy, Adjuvant. Reoperation. Retrospective Studies. Survival Analysis

  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16798228.001).
  • [ISSN] 1552-6259
  • [Journal-full-title] The Annals of thoracic surgery
  • [ISO-abbreviation] Ann. Thorac. Surg.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] Netherlands
  •  go-up   go-down


20. Skuballa A: [Surgical therapy of bronchial carcinoma]. MMW Fortschr Med; 2007 Nov 1;149(44):30-1
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Surgical therapy of bronchial carcinoma].
  • [Transliterated title] Chirurgische Therapie des Bronchialkarzinoms. Trend zur multimodalen Behandlung.
  • Chest surgery is a fundamental component of the interdisciplinary diagnostic and therapeutic procedures for lung cancer.
  • [MeSH-major] Carcinoma, Non-Small-Cell Lung / surgery. Carcinoma, Small Cell / surgery. Lung Neoplasms / surgery
  • [MeSH-minor] Combined Modality Therapy. Humans. Lung / pathology. Lymph Node Excision. Neoadjuvant Therapy. Neoplasm Staging. Pancoast Syndrome / surgery. Pneumonectomy. Prognosis. Thoracic Surgery, Video-Assisted. Time Factors. Treatment Outcome

  • MedlinePlus Health Information. consumer health - Lung Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18078167.001).
  • [ISSN] 1438-3276
  • [Journal-full-title] MMW Fortschritte der Medizin
  • [ISO-abbreviation] MMW Fortschr Med
  • [Language] ger
  • [Publication-type] Comparative Study; English Abstract; Journal Article; Review
  • [Publication-country] Germany
  • [Number-of-references] 0
  •  go-up   go-down


21. Hautmann H, Pichler JP, Stepp H, Baumgartner R, Gamarra F, Huber RM: In-vivo kinetics of inhaled 5-aminolevulinic acid-induced protoporphyrin IX fluorescence in bronchial tissue. Respir Res; 2007;8:33
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] In-vivo kinetics of inhaled 5-aminolevulinic acid-induced protoporphyrin IX fluorescence in bronchial tissue.
  • BACKGROUND: In the diagnosis of early-stage lung cancer photosensitizer-enhanced fluorescence bronchoscopy with inhaled 5-aminolevolinic acid (5-ALA) increases sensitivity when compared to white-light bronchoscopy.
  • This investigation was to evaluate the in vivo tissue pharmacokinetics of inhaled 5-ALA within the bronchial mucosa in order to define the time optimum for its application prior to bronchoscopy.
  • METHODS: Patients with known or suspected bronchial carcinoma were randomized to receive 200 mg 5-ALA via inhalation 1, 2, 3, 4 or 6 hours before flexible fluorescence bronchoscopy was performed.
  • RESULTS: Fluorescence bronchoscopy performed in 19 patients reveals a sensitivity for malignant and premalignant changes (moderate dysplasia) which is almost twice as high as that of white-light bronchoscopy, whereas specificity is reduced.
  • Malignant and premalignant alterations produced fluorescence values that are up to 5 times higher than those of normal tissue.
  • [MeSH-major] Aminolevulinic Acid / pharmacokinetics. Bronchi / metabolism. Bronchi / pathology. Bronchial Neoplasms / metabolism. Bronchial Neoplasms / pathology. Bronchoscopy / methods. Protoporphyrins

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Eur Respir J Suppl. 2003 Jan;39:57s-66s [12572703.001]
  • [Cites] Respiration. 2002;69(5):445-50 [12232453.001]
  • [Cites] J Photochem Photobiol B. 2004 Jan 23;73(1-2):35-42 [14732249.001]
  • [Cites] Monaldi Arch Chest Dis. 2004 Apr-Jun;61(2):86-93 [15510708.001]
  • [Cites] Lasers Surg Med. 1984;4(1):49-58 [6235415.001]
  • [Cites] Am Rev Respir Dis. 1984 Oct;130(4):545-9 [6548343.001]
  • [Cites] Clin Chest Med. 1985 Jun;6(2):237-53 [3161683.001]
  • [Cites] Chest. 1989 Oct;96(4):919-21 [2529106.001]
  • [Cites] Lasers Surg Med. 1991;11(2):99-105 [2034016.001]
  • [Cites] J Photochem Photobiol B. 1992 Jul 30;14(4):275-92 [1403373.001]
  • [Cites] Photochem Photobiol. 1996 Oct;64(4):676-82 [8863473.001]
  • [Cites] J Photochem Photobiol B. 1996 Nov;36(2):169-74 [9002254.001]
  • [Cites] Chest. 1998 Mar;113(3):696-702 [9515845.001]
  • [Cites] Thorax. 2005 Jun;60(6):496-503 [15923251.001]
  • [Cites] Thorax. 2006 Apr;61(4):364 [16565272.001]
  • [Cites] Semin Surg Oncol. 2000 Mar;18(2):106-15 [10657912.001]
  • [Cites] Cancer. 2000 Dec 1;89(11 Suppl):2468-73 [11147629.001]
  • [Cites] Respiration. 2003 Jul-Aug;70(4):395-8 [14512675.001]
  • (PMID = 17445266.001).
  • [ISSN] 1465-993X
  • [Journal-full-title] Respiratory research
  • [ISO-abbreviation] Respir. Res.
  • [Language] eng
  • [Publication-type] Journal Article; Randomized Controlled Trial
  • [Publication-country] England
  • [Chemical-registry-number] 0 / Photosensitizing Agents; 0 / Protoporphyrins; 553-12-8 / protoporphyrin IX; 88755TAZ87 / Aminolevulinic Acid
  • [Other-IDs] NLM/ PMC1868083
  •  go-up   go-down


22. Chae EJ, Seo JB, Kim SY, Do KH, Heo JN, Lee JS, Song KS, Song JW, Lim TH: Radiographic and CT findings of thoracic complications after pneumonectomy. Radiographics; 2006 Sep-Oct;26(5):1449-68
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Pneumonectomy is the treatment of choice for bronchogenic carcinoma and intractable end-stage lung diseases such as tuberculosis and bronchiectasis, but it is often followed by postoperative complications, which account for significant morbidity and mortality.
  • Early complications of pneumonectomy include pulmonary edema, bronchopleural fistula, pneumonia of the contralateral lung, empyema, and adult respiratory distress syndrome, which may occur separately or in combination.
  • Late postpneumonectomy complications include recurrent disease, infection, effects of radiation therapy or chemotherapy, and surgical complications such as late-onset bronchopleural fistula, postpneumonectomy syndrome, and esophagopleural fistula.
  • When the radiographic findings are inconclusive, computed tomography is helpful for establishing a diagnosis and obtaining detailed information about the disease process.
  • [MeSH-major] Bronchial Diseases / etiology. Bronchial Diseases / radiography. Esophageal Diseases / etiology. Esophageal Diseases / radiography. Lung Diseases / etiology. Lung Diseases / radiography. Pneumonectomy / adverse effects

  • MedlinePlus Health Information. consumer health - Bronchial Disorders.
  • MedlinePlus Health Information. consumer health - Esophagus Disorders.
  • MedlinePlus Health Information. consumer health - Lung Diseases.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] Copyright RSNA, 2006.
  • (PMID = 16973775.001).
  • [ISSN] 1527-1323
  • [Journal-full-title] Radiographics : a review publication of the Radiological Society of North America, Inc
  • [ISO-abbreviation] Radiographics
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article; Review
  • [Publication-country] United States
  • [Number-of-references] 70
  •  go-up   go-down


23. Estrada Trigueros G, Comeche L, López Encuentra A, Montoro Zulueta J, González Garrido F, Colina F: [Bronchogenic carcinoma 2000-2001: characteristics and overall survival]. Arch Bronconeumol; 2007 Nov;43(11):594-8
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Bronchogenic carcinoma 2000-2001: characteristics and overall survival].
  • [Transliterated title] Carcinoma broncogénico 2000-2001: características y supervivencia global.
  • OBJECTIVE: To describe the clinical characteristics and survival of patients diagnosed with bronchogenic carcinoma during the years 2000 and 2001 in a tertiary level hospital.
  • Of all the patients diagnosed with or treated for bronchogenic carcinoma in our hospital, only those from our health care area were selected.
  • Large cell carcinomas accounted for 29.4% of cases.
  • Of all the cases of bronchogenic carcinoma, 41.3% were diagnosed in stage IV.
  • Thirty percent of non-small cell carcinomas were classified as stage I, compared to 6% of small cell carcinomas (P< .001).
  • The overall 5-year survival rate was 13% (95% confidence interval [CI], 10%-16%), while survival was significantly lower in patients aged 68 years or older (95% CI, 3%-15%; P< .001) and in patients with small cell carcinoma (0%, P< .01).
  • CONCLUSIONS: Our recent experience (2000-2001) confirmed the advanced age of patients with bronchogenic carcinoma, the frequency of diagnosis in advanced stages of the disease (41% in stage IV), and the low overall 5-year survival rate (13%).
  • [MeSH-major] Carcinoma, Bronchogenic / epidemiology. Lung Neoplasms / epidemiology

  • MedlinePlus Health Information. consumer health - Lung Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17983542.001).
  • [ISSN] 0300-2896
  • [Journal-full-title] Archivos de bronconeumología
  • [ISO-abbreviation] Arch. Bronconeumol.
  • [Language] spa
  • [Publication-type] English Abstract; Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] Spain
  •  go-up   go-down


24. Hosny G, Akel M: Assessment of asbestos in drinking water in alexandria, egypt. J Egypt Public Health Assoc; 2006;81(3-4):181-98
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • The health hazards associated with inhalation of asbestos in the occupational environment have long been recognized including asbestosis, bronchial carcinoma, malignant mesothelioma of the pleura and peritoneum, and possibly cancers of the gastrointestinal tract and larynx.

  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17382060.001).
  • [ISSN] 0013-2446
  • [Journal-full-title] The Journal of the Egyptian Public Health Association
  • [ISO-abbreviation] J Egypt Public Health Assoc
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] Egypt
  •  go-up   go-down


25. van Geel AN, van der Pol C, Notenboom A, Nuyttens JJ, Eggermont AM, Surmont V, Maat AP: [Long-term results of the multidisciplinary surgical treatment of non-small-cell bronchial carcinoma in the superior sulcus (Pancoast tumour): a retrospective study]. Ned Tijdschr Geneeskd; 2007 Jun 23;151(25):1406-11
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Long-term results of the multidisciplinary surgical treatment of non-small-cell bronchial carcinoma in the superior sulcus (Pancoast tumour): a retrospective study].
  • [Transliterated title] Langetermijnresultaten van de multidisciplinaire chirurgische behandeling van niet-kleincellig bronchuscarcinoom in de thoraxkoepel (pancoasttumor); retrospectief onderzoek.
  • METHODS: During the period from 1 January 1991 to 31 December 2004, 36 patients underwent surgical treatment combined with radiotherapy or chemoradiotherapy for a non-small-cell bronchial carcinoma with invasion of the superior sulcus.
  • The data were analysed according to the intention-to-treat principle, with overall survival and disease-free survival as the outcome variables.
  • RESULTS: 36 patients with a non-small-cell bronchial carcinoma invading the superior sulcus (Pancoast tumour) underwent multidisciplinary treatment consisting of pre-operative radiotherapy (since 2002 concomitant chemoradiotherapy), superior-sulcus resection and (partial) lung resection with intra-operative brachytherapy.
  • The 2-year overall and disease-free survival was 45 and 31%, respectively, and at 5 years this was 28 and 19%.
  • These results were comparable with those for stage IIB lung cancer without invasion.
  • [MeSH-major] Carcinoma, Non-Small-Cell Lung / radiotherapy. Carcinoma, Non-Small-Cell Lung / surgery. Lung Neoplasms / radiotherapy. Lung Neoplasms / surgery. Pancoast Syndrome / radiotherapy. Pancoast Syndrome / surgery
  • [MeSH-minor] Adult. Age Factors. Aged. Combined Modality Therapy. Disease-Free Survival. Female. Humans. Lymphatic Metastasis. Male. Middle Aged. Neoplasm Staging. Pneumonectomy. Postoperative Care. Preoperative Care. Prognosis. Proportional Hazards Models. Retrospective Studies. Survival Analysis. Time Factors. Treatment Outcome

  • MedlinePlus Health Information. consumer health - Lung Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [CommentIn] Ned Tijdschr Geneeskd. 2007 Jun 23;151(25):1382-4 [17668598.001]
  • (PMID = 17668607.001).
  • [ISSN] 0028-2162
  • [Journal-full-title] Nederlands tijdschrift voor geneeskunde
  • [ISO-abbreviation] Ned Tijdschr Geneeskd
  • [Language] dut
  • [Publication-type] English Abstract; Journal Article
  • [Publication-country] Netherlands
  •  go-up   go-down


26. Giuliani L, Jaxmar T, Casadio C, Gariglio M, Manna A, D'Antonio D, Syrjanen K, Favalli C, Ciotti M: Detection of oncogenic viruses SV40, BKV, JCV, HCMV, HPV and p53 codon 72 polymorphism in lung carcinoma. Lung Cancer; 2007 Sep;57(3):273-81
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Detection of oncogenic viruses SV40, BKV, JCV, HCMV, HPV and p53 codon 72 polymorphism in lung carcinoma.
  • As a part of our continuous search for oncogenic viruses in bronchial cancer, we extended our HPV studies to analyse also SV40, BKV, JCV and HCMV sequences in bronchial cancer and related these data with p53 codon 72 polymorphism.
  • Fresh tumor samples from 78 patients with lung cancer were analysed for SV40, BKV, JCV, HCMV and HPV sequences by PCR.
  • [MeSH-major] Carcinoma / virology. Genetic Predisposition to Disease. Lung Neoplasms / virology. Oncogenic Viruses / isolation & purification. Polymorphism, Genetic. Tumor Suppressor Protein p53 / genetics

  • MedlinePlus Health Information. consumer health - Lung Cancer.
  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17400331.001).
  • [ISSN] 0169-5002
  • [Journal-full-title] Lung cancer (Amsterdam, Netherlands)
  • [ISO-abbreviation] Lung Cancer
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] Ireland
  • [Chemical-registry-number] 0 / Codon; 0 / Tumor Suppressor Protein p53
  •  go-up   go-down


27. Roeseler A, Burns D: The quarter that changed the world. Tob Control; 2010 Apr;19 Suppl 1:i3-15
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • From 1988 to 2004, lung and bronchus cancer rates in California declined at nearly four times the rate of decline seen in the rest of the USA and the programme is associated with an $86 billion savings in healthcare costs.
  • [MeSH-major] Health Promotion / organization & administration. Lung Neoplasms / prevention & control. Smoking / epidemiology. Tobacco Industry. Tobacco Use Cessation / statistics & numerical data. Tobacco Use Disorder / prevention & control

  • MedlinePlus Health Information. consumer health - Lung Cancer.
  • MedlinePlus Health Information. consumer health - Smoking.
  • MedlinePlus Health Information. consumer health - Smoking and Youth.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Health Psychol. 2005 Jan;24(1):22-31 [15631559.001]
  • [Cites] Cancer. 1998 Dec 15;83(12 Suppl Robert):2717-21 [9874384.001]
  • [Cites] Tob Control. 2006 Feb;15(1):50-8 [16436406.001]
  • [Cites] MMWR Morb Mortal Wkly Rep. 2006 Oct 27;55(42):1145-8 [17065979.001]
  • [Cites] PLoS Med. 2008 Aug 26;5(8):e178 [18752344.001]
  • [Cites] Tob Control. 1998 Winter;7(4):397-408 [10093175.001]
  • [Cites] Am J Public Health. 2000 May;90(5):762-7 [10800426.001]
  • [Cites] Public Health Rep. 2000 Mar-Jun;115(2-3):212-5 [10968756.001]
  • [Cites] N Engl J Med. 2000 Dec 14;343(24):1772-7 [11114317.001]
  • [Cites] MMWR Morb Mortal Wkly Rep. 2000 Dec 1;49(47):1066-9 [11186612.001]
  • [Cites] J Clin Oncol. 2001 Sep 15;19(18 Suppl):69S-73S [11560977.001]
  • [Cites] Am J Public Health. 2002 Jun;92(6):975-83 [12036792.001]
  • [Cites] Cancer Causes Control. 2004 Sep;15(7):689-95 [15280627.001]
  • [Cites] JAMA. 1994 Oct 19;272(15):1176-82 [7933347.001]
  • [Cites] Health Aff (Millwood). 1996 Spring;15(1):58-72 [8920569.001]
  • [Cites] Tob Control. 1996 Autumn;5(3):189-91 [9035352.001]
  • [Cites] Am J Public Health. 1998 Jun;88(6):918-23 [9618620.001]
  • [Cites] Public Health Rep. 2005 Sep-Oct;120(5):482-95 [16224981.001]
  • (PMID = 20382647.001).
  • [ISSN] 1468-3318
  • [Journal-full-title] Tobacco control
  • [ISO-abbreviation] Tob Control
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] England
  • [Other-IDs] NLM/ PMC2976491
  •  go-up   go-down


28. Cakir E, Demirag F, Aydin M: Cytopathologic differential diagnosis of small cell carcinoma and poorly differentiated non-small cell carcinoma in bronchial lavage specimens using a regression analysis. APMIS; 2010 Feb;118(2):150-5
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Cytopathologic differential diagnosis of small cell carcinoma and poorly differentiated non-small cell carcinoma in bronchial lavage specimens using a regression analysis.
  • The aim of this study was to determine the most significant cytologic features to differentiate small cell carcinoma (SCC) from poorly differentiated non-small cell carcinoma (NSCC) in bronchial lavage specimens.
  • Bronchial lavage specimens from 35 SCC cases and 63 poorly differentiated NSCC cases were examined and the cytologic parameters reviewed retrospectively.
  • Thirty-five cytologic features considered useful in differential diagnosis were assessed.
  • [MeSH-major] Bronchi / pathology. Carcinoma, Non-Small-Cell Lung / diagnosis. Lung Neoplasms / diagnosis. Small Cell Lung Carcinoma / diagnosis
  • [MeSH-minor] Aged. Bronchoalveolar Lavage. Diagnosis, Differential. Female. Humans. Male. Middle Aged. Regression Analysis

  • MedlinePlus Health Information. consumer health - Lung Cancer.
  • NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 20132179.001).
  • [ISSN] 1600-0463
  • [Journal-full-title] APMIS : acta pathologica, microbiologica, et immunologica Scandinavica
  • [ISO-abbreviation] APMIS
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] Denmark
  •  go-up   go-down


29. Ishizumi T, Tateishi U, Watanabe S, Maeda T, Arai Y: F-18 FDG PET/CT imaging of low-grade mucoepidermoid carcinoma of the bronchus. Ann Nucl Med; 2007 Jul;21(5):299-302
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] F-18 FDG PET/CT imaging of low-grade mucoepidermoid carcinoma of the bronchus.
  • Mucoepidermoid carcinomas in the bronchial tree are extremely rare tumors.
  • Fluorine-18-fluorodeoxyglucose positron emission tomography (F-18 FDG PET) is a useful technique for the evaluation of pulmonary lesions; however, to our knowledge, F-18 FDG PET findings in mucoepidermoid carcinoma of the bronchus have been described in only a few cases.
  • Identifiable focal F-18 FDG uptake has been reported in high-grade mucoepidermoid carcinoma, but it is unclear whether F-18 FDG accumulates in low-grade mucoepidermoid carcinoma.
  • Here, we present the case of a 37-year-old woman, with pathologically proven low-grade mucoepidermoid carcinoma, who underwent high-resolution computed tomography (CT) and F-18 FDG PET/CT before treatment.
  • [MeSH-major] Bronchial Neoplasms / diagnosis. Bronchial Neoplasms / radionuclide imaging. Carcinoma, Mucoepidermoid / diagnosis. Carcinoma, Mucoepidermoid / radionuclide imaging. Fluorodeoxyglucose F18. Positron-Emission Tomography / methods. Radiopharmaceuticals. Tomography, X-Ray Computed / methods
  • [MeSH-minor] Adult. Female. Humans. Image Processing, Computer-Assisted. Lung / pathology

  • Genetic Alliance. consumer health - Mucoepidermoid carcinoma.
  • MedlinePlus Health Information. consumer health - CT Scans.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17634848.001).
  • [ISSN] 0914-7187
  • [Journal-full-title] Annals of nuclear medicine
  • [ISO-abbreviation] Ann Nucl Med
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] Japan
  • [Chemical-registry-number] 0 / Radiopharmaceuticals; 0Z5B2CJX4D / Fluorodeoxyglucose F18
  •  go-up   go-down


30. Prasad R, Verma SK, Sanjay: Comparison between young and old patients with bronchogenic carcinoma. J Cancer Res Ther; 2009 Jan-Mar;5(1):31-5
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Comparison between young and old patients with bronchogenic carcinoma.
  • OBJECTIVE: This study was undertaken to explore the clinicopathological profile of bronchogenic carcinoma in young patients.
  • MATERIALS AND METHODS: The present study was conducted on 799 consecutive histopathologically proven cases of bronchogenic carcinoma that were referred from different parts of Uttar Pradesh.
  • Squamous cell carcinoma was the commonest histological subtype in both the groups, but squamous cell carcinoma was more frequently diagnosed in older patients than in younger patients.
  • CONCLUSION: This study suggests that, regardless of age or sex, lung cancer must be ruled out in all patients who have persistent signs of pulmonary disease and a history of heavy smoking.
  • [MeSH-major] Carcinoma, Bronchogenic / pathology. Carcinoma, Bronchogenic / physiopathology. Lung Neoplasms / pathology. Lung Neoplasms / physiopathology. Smoking / adverse effects
  • [MeSH-minor] Adult. Carcinoma, Squamous Cell / etiology. Carcinoma, Squamous Cell / pathology. Carcinoma, Squamous Cell / physiopathology. Female. Humans. Male. Middle Aged. Neoplasm Staging

  • MedlinePlus Health Information. consumer health - Lung Cancer.
  • MedlinePlus Health Information. consumer health - Smoking.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19293486.001).
  • [ISSN] 1998-4138
  • [Journal-full-title] Journal of cancer research and therapeutics
  • [ISO-abbreviation] J Cancer Res Ther
  • [Language] eng
  • [Publication-type] Comparative Study; Journal Article
  • [Publication-country] India
  •  go-up   go-down


31. Wang GF, Lai MD, Yang RR, Chen PH, Su YY, Lv BJ, Sun LP, Huang Q, Chen SZ: Histological types and significance of bronchial epithelial dysplasia. Mod Pathol; 2006 Mar;19(3):429-37
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Histological types and significance of bronchial epithelial dysplasia.
  • Pulmonary epithelium is known to undergo a preneoplastic process prior to the development of lung carcinoma.
  • Squamous dysplasia and atypical adenomatous hyperplasia have been identified and classified as preinvasive lesions of squamous cell carcinoma and peripheral pulmonary adenocarcinoma, respectively.
  • However, these commonly recognized preinvasive lesions do not completely explain the development of all histological types of lung carcinoma.
  • By examining 114 resection lung specimens, we concluded that there are four histological patterns of bronchial epithelial dysplasia based on morphological features (basal cell dysplasia, columnar cell dysplasia, bronchial epithelial dysplasia with transitional differentiation, and squamous dysplasia).
  • Basal cell dysplasia was focally positive for cytokeratin (CK) 17 and 10/13; columnar cell dysplasia was generally positive for CK7, 8, and 18; bronchial epithelial dysplasia with transitional differentiation had a heterogeneous immunoprofile, while squamous dysplasia was positive for CK10/13 and focally positive for CK17.
  • Various degrees of abnormal expression of p53 and Ki-67 were found in the different types of bronchial epithelial dysplasia.
  • The cases were divided into three groups based on degree and extent of bronchial epithelial dysplasia.
  • By Crosstabs McNemar test, the Mann-Whitney U-test (for two independent groups), the Kruskal-Wallis one-way nonparametric ANOVA (for >2 independent groups) and Spearman correlation analysis, the degree and extent of bronchial epithelial dysplasia was shown to be positively correlated with the incidence of bronchogenic carcinoma and multifocal primary lung carcinoma (P<0.05).
  • (1) bronchial epithelium can develop various patterns of dysplasia with abnormal/ambiguous cell differentiation and abnormal expressions of p53 and Ki-67.
  • Thus, these bronchial epithelial dysplastic lesions may represent a preneoplastic process. (2) The degree of bronchial epithelial dysplasia may significantly predispose individuals to bronchogenic carcinoma and multifocal primary lung carcinoma.
  • [MeSH-major] Lung Neoplasms / pathology. Precancerous Conditions / pathology
  • [MeSH-minor] Adult. Aged. Bronchial Neoplasms / metabolism. Bronchial Neoplasms / pathology. Carcinoma, Bronchogenic / metabolism. Carcinoma, Bronchogenic / pathology. Cell Differentiation. Epithelial Cells / chemistry. Epithelial Cells / pathology. Female. Humans. Immunohistochemistry. Keratins / analysis. Ki-67 Antigen / analysis. Male. Middle Aged. Respiratory Mucosa / chemistry. Respiratory Mucosa / pathology. Tumor Suppressor Protein p53 / analysis

  • MedlinePlus Health Information. consumer health - Lung Cancer.
  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16415791.001).
  • [ISSN] 0893-3952
  • [Journal-full-title] Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc
  • [ISO-abbreviation] Mod. Pathol.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Ki-67 Antigen; 0 / Tumor Suppressor Protein p53; 68238-35-7 / Keratins
  •  go-up   go-down


32. Duque JL, Rami-Porta R, Almaraz A, Castanedo M, Freixinet J, Fernández de Rota A, López Encuentra A, Grupo Cooperativo del Carcinoma Broncogénico SEPAR: [Risk factors in bronchogenic carcinoma surgery]. Arch Bronconeumol; 2007 Mar;43(3):143-9
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Risk factors in bronchogenic carcinoma surgery].
  • [Transliterated title] Parámetros de riesgo en la cirugía del carcinoma broncogénico.
  • OBJECTIVE: To analyze the factors that determine the risk of morbidity and mortality associated with lung resection in patients with bronchogenic carcinoma.
  • PATIENTS AND METHODS: Prospective multicenter study conducted between October 1, 1993 and September 30, 1997 in the 19 hospitals that make up the Bronchogenic Carcinoma Cooperative Group.
  • During the study period, 2994 patients with bronchogenic carcinoma underwent surgery.
  • CONCLUSIONS: Surgical treatment of bronchogenic carcinoma in Spain is associated with high morbidity and mortality.
  • [MeSH-major] Carcinoma, Bronchogenic / surgery. Lung Neoplasms / surgery. Pneumonectomy / statistics & numerical data. Postoperative Complications / etiology

  • MedlinePlus Health Information. consumer health - After Surgery.
  • MedlinePlus Health Information. consumer health - Lung Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17386190.001).
  • [ISSN] 0300-2896
  • [Journal-full-title] Archivos de bronconeumología
  • [ISO-abbreviation] Arch. Bronconeumol.
  • [Language] spa
  • [Publication-type] English Abstract; Journal Article
  • [Publication-country] Spain
  •  go-up   go-down


33. Rodrigues Gda S, Severo CB, Oliveira Fde M, Moreira Jda S, Prolla JC, Severo LC: Association between paracoccidioidomycosis and cancer. J Bras Pneumol; 2010 May-Jun;36(3):356-62
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Association between paracoccidioidomycosis and cancer.
  • OBJECTIVE: To analyze the association between paracoccidioidomycosis (Pcm) and cancer in a series of 25 cases and to review the literature on this topic.
  • METHODS: A retrospective review of 25 cases diagnosed with Pcm and cancer, retrieved from a series of 808 consecutive adult patients diagnosed with Pcm based on tests conducted in the Mycology Laboratory of the Santa Casa Complexo Hospitalar, in the city of Porto Alegre, Brazil, between 1972 and 2007.
  • The diagnosis of Pcm was confirmed by means of direct microscopic examination, histopathological examination or immunodiffusion test.
  • All cancer cases were confirmed by histopathological or cytopathological examination.
  • The most prevalent tumor was bronchial carcinoma, in 15 patients, followed by other types of carcinoma, and 1 patient had Hodgkin's lymphoma.
  • The most common treatment for cancer was surgery, followed by radiotherapy and chemotherapy.
  • In the general population of the area under study, the prevalence of lung cancer was significantly higher in smokers with Pcm than in smokers without Pcm (p < 0.001).
  • CONCLUSIONS: A diagnosis of Pcm appears to increase the risk of lung cancer.
  • [MeSH-major] Carcinoma, Bronchogenic / complications. Lung Neoplasms / complications. Paracoccidioidomycosis / complications

  • Genetic Alliance. consumer health - Paracoccidioidomycosis.
  • MedlinePlus Health Information. consumer health - Lung Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [CommentIn] J Bras Pneumol. 2010 Sep-Oct;36(5):666 [21085834.001]
  • (PMID = 20625674.001).
  • [ISSN] 1806-3756
  • [Journal-full-title] Jornal brasileiro de pneumologia : publicaça̋o oficial da Sociedade Brasileira de Pneumologia e Tisilogia
  • [ISO-abbreviation] J Bras Pneumol
  • [Language] eng; por
  • [Publication-type] Journal Article; Review
  • [Publication-country] Brazil
  •  go-up   go-down


34. Jamnik S, Uehara C, da Silva VV: Location of lung carcinoma in relation to the smoking habit and gender. J Bras Pneumol; 2006 Nov-Dec;32(6):510-4
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Location of lung carcinoma in relation to the smoking habit and gender.
  • OBJECTIVE: To analyze the locations of lung carcinomas in relation to patient gender and smoking status.
  • METHODS: In order to test the hypothesis that lung carcinoma location (upper or lower lobe; left or right side) is correlated with smoking status and gender, we conducted a retrospective study of 697 patients with bronchogenic carcinoma treated at the Pulmonology-Oncology Outpatient Clinic of the Federal University of São Paulo.
  • RESULTS: We found that the bronchogenic carcinomas occurring in smokers were more frequently located in the upper lobes, whereas those occurring in nonsmokers were more frequently located in the lower lobes.
  • CONCLUSION: Overall, bronchogenic carcinomas are predominantly found in the upper lobes.
  • In females, bronchogenic carcinomas present a tendency to occur more often in the lower lobes.
  • [MeSH-major] Carcinoma, Bronchogenic / pathology. Lung Neoplasms / etiology. Lung Neoplasms / pathology. Smoking / adverse effects

  • MedlinePlus Health Information. consumer health - Lung Cancer.
  • MedlinePlus Health Information. consumer health - Smoking.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17435901.001).
  • [ISSN] 1806-3756
  • [Journal-full-title] Jornal brasileiro de pneumologia : publicaça̋o oficial da Sociedade Brasileira de Pneumologia e Tisilogia
  • [ISO-abbreviation] J Bras Pneumol
  • [Language] eng; por
  • [Publication-type] Comparative Study; Journal Article
  • [Publication-country] Brazil
  •  go-up   go-down


35. Peer FI, Pui MH, Rae WI, Mosam A: 99mTc-MIBI imaging of AIDS-related Kaposi's sarcoma in the lungs. Nucl Med Commun; 2008 Sep;29(9):786-90
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Prompt detection, diagnosis, and treatment reduce patient morbidity and mortality.
  • METHODS: 99mTc-MIBI imaging was performed on 72 human immunodeficiency virus-seropositive patients with bronchoscopic diagnosis of pulmonary KS (36 patients), pneumonia (22), normal tracheo-bronchial tree (11), lymphoma (2), and bronchogenic carcinoma (1).
  • Lung uptake and lymph node detection in KS were compared on planar and single photon emission computed tomography (SPECT) scans.
  • RESULTS: The lung/myocardium ratios on the 1-h planar images were significantly higher in KS and normal lungs than opportunistic infection.
  • Using the lung/myocardium ratio of 1 as cutoff, the sensitivity, specificity, and accuracy of the 1-h planar images for detecting pulmonary KS were 75, 57.58, and 66.67%, respectively.
  • [MeSH-major] Acquired Immunodeficiency Syndrome / complications. Lung Neoplasms / radionuclide imaging. Sarcoma, Kaposi / radionuclide imaging. Technetium Tc 99m Sestamibi
  • [MeSH-minor] Adult. Aged. Female. Humans. Lymphatic Metastasis / diagnosis. Lymphatic Metastasis / radionuclide imaging. Male. Middle Aged. Myocardium / metabolism. Reproducibility of Results. Time Factors. Tomography, Emission-Computed, Single-Photon / methods


36. Ghetie C, Davies M, Cornfeld D, Suh N, Saif MW: Expectoration of a lung metastasis in a patient with colorectal carcinoma. Clin Colorectal Cancer; 2008 Jul;7(4):283-6
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Expectoration of a lung metastasis in a patient with colorectal carcinoma.
  • Metastatic disease is present in up to 20% of patients at the time of diagnosis of colorectal cancer.
  • A rare form of lung metastatic disease is endobronchial metastases, most commonly seen with breast cancer and colon cancer.
  • Their clinical and imaging profile is similar to primary bronchogenic carcinoma.
  • Tumor expectoration is an unusual manifestation of endobronchial metastases (as well as of the primary lung carcinoma).
  • We report the case of a 75-year-old man with known liver and lung metastatic disease from colon cancer who experienced an episode of tissue expectoration.
  • Most of the cases reported include secondary lung malignancies, with renal cell carcinoma being the most common primary site.
  • Endobronchial metastases from colon cancer are rare.
  • Patients with colon cancer can benefit from sputum cytology because this type of metastases is shown to have exfoliative properties.
  • To assess the need for endobronchial management with stent placement or bracytherapy, bronchoscopy should be considered in certain circumstances (the onset of respiratory symptoms, rapid response to chemotherapy, long history of metastatic disease with multiple systemic therapies given, undulating response in tumor, as well as after a reported episode of tissue expectoration).
  • [MeSH-major] Adenocarcinoma / secondary. Colorectal Neoplasms / pathology. Cough / etiology. Hemoptysis / etiology. Lung Neoplasms / secondary. Sputum

  • MedlinePlus Health Information. consumer health - Colorectal Cancer.
  • MedlinePlus Health Information. consumer health - Cough.
  • MedlinePlus Health Information. consumer health - Lung Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18650198.001).
  • [ISSN] 1533-0028
  • [Journal-full-title] Clinical colorectal cancer
  • [ISO-abbreviation] Clin Colorectal Cancer
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article; Review
  • [Publication-country] United States
  • [Number-of-references] 29
  •  go-up   go-down


37. Jensen D, Andersen PE: [Embolisation in connection with haemoptysis]. Ugeskr Laeger; 2009 Aug 31;171(36):2575
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Embolisation of pathologic systemic collateral arteries to the bronchial artery system can be an effective option for haemoptysis control.
  • Globally, tuberculosis is the most frequent cause of haemoptysis, but bronchitis, bronchiectasis, bronchogenic carcinoma and other inflammatory diseases are more frequent in the western world.
  • In the majority of cases, a bronchial artery is the bleeding source, but in approx.
  • [MeSH-minor] Bronchial Arteries. Female. Humans. Mammary Arteries. Middle Aged. Pulmonary Veins

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19732552.001).
  • [ISSN] 1603-6824
  • [Journal-full-title] Ugeskrift for laeger
  • [ISO-abbreviation] Ugeskr. Laeg.
  • [Language] dan
  • [Publication-type] Case Reports; English Abstract; Journal Article
  • [Publication-country] Denmark
  •  go-up   go-down


38. Prabhu S, Sripathi H, Rao R, Hameed S: Thoracopulmonary actinomycosis: the masquerader. Clin Exp Dermatol; 2008 May;33(3):262-5
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Thoracopulmonary actinomycosis can mimic various lung pathologies such as bronchogenic carcinoma, tuberculosis and fungal pneumonia, to name but a few.
  • The disease is successfully diagnosed only if there is a high index of suspicion and a thorough evaluation with multidisciplinary involvement.
  • [MeSH-major] Actinomycosis / diagnosis. Lung Diseases / diagnosis
  • [MeSH-minor] Adult. Anti-Bacterial Agents / administration & dosage. Diagnosis, Differential. Humans. Injections, Intravenous. Male. Penicillin G / administration & dosage. Penicillin V / administration & dosage. Prognosis. Tomography, X-Ray Computed. Treatment Outcome. Tuberculosis, Pulmonary / diagnosis

  • Genetic Alliance. consumer health - Anaerobic Actinomyces Infection.
  • MedlinePlus Health Information. consumer health - Lung Diseases.
  • Hazardous Substances Data Bank. PENICILLIN VK .
  • Hazardous Substances Data Bank. PENICILLIN G .
  • Hazardous Substances Data Bank. PENICILLIN V .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18076682.001).
  • [ISSN] 0307-6938
  • [Journal-full-title] Clinical and experimental dermatology
  • [ISO-abbreviation] Clin. Exp. Dermatol.
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] England
  • [Chemical-registry-number] 0 / Anti-Bacterial Agents; Q42T66VG0C / Penicillin G; Z61I075U2W / Penicillin V
  •  go-up   go-down


39. Halleck P, Haisch A, Sedlmaier B: [Differential diagnoses of acute bilateral hearing loss in a patient with metastatic bronchial carcinoma]. HNO; 2006 Jul;54(7):553-6
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Differential diagnoses of acute bilateral hearing loss in a patient with metastatic bronchial carcinoma].
  • [Transliterated title] Differenzialdiagnosen einer beidseitigen akuten Hörminderung bei einem Patienten mit metastasierendem Bronchialkarzinom.
  • Cerebellar and hepatic metastases from a bronchial carcinoma were previously diagnosed in the case presented here, and the most probable causes of the progressive hearing loss, e.g. idiopathic sudden deafness, infection and tumor-associated factors, were considered and diagnostically analyzed.
  • [MeSH-major] Bronchial Neoplasms / diagnosis. Hearing Loss, Bilateral / diagnosis. Hearing Loss, Bilateral / etiology. Neuroma, Acoustic / diagnosis. Neuroma, Acoustic / secondary
  • [MeSH-minor] Acute Disease. Diagnosis, Differential. Humans. Male. Middle Aged

  • MedlinePlus Health Information. consumer health - Acoustic Neuroma.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Rev Neurol. 2000 Dec 16-31;31(12):1213-9 [11205562.001]
  • [Cites] Med Klin (Munich). 2001 Sep 15;96(9):545-9 [11603118.001]
  • [Cites] J Exp Clin Cancer Res. 2003 Mar;22(1):155-8 [12725337.001]
  • [Cites] Anticancer Res. 2003 Mar-Apr;23(2B):1249-55 [12820379.001]
  • (PMID = 16132878.001).
  • [ISSN] 0017-6192
  • [Journal-full-title] HNO
  • [ISO-abbreviation] HNO
  • [Language] ger
  • [Publication-type] Case Reports; English Abstract; Journal Article
  • [Publication-country] Germany
  •  go-up   go-down


40. Müller CS, Lorenz MT, Tilgen W, Rass K: Primary manifestation of erythema gyratum repens as a transient erythroderma in a patient with bronchial carcinoma. Int J Dermatol; 2010 Jun;49(6):676-8
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Primary manifestation of erythema gyratum repens as a transient erythroderma in a patient with bronchial carcinoma.
  • [MeSH-major] Bronchial Neoplasms / complications. Carcinoma, Non-Small-Cell Lung / complications. Dermatitis, Exfoliative / etiology. Erythema / etiology. Paraneoplastic Syndromes / pathology

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 20618474.001).
  • [ISSN] 1365-4632
  • [Journal-full-title] International journal of dermatology
  • [ISO-abbreviation] Int. J. Dermatol.
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] United States
  •  go-up   go-down


41. Decker G, De Leyn P: [The pre-operative assessment of bronchial carcinoma. The surgeon's viewpoint]. Rev Mal Respir; 2005 Sep;22(4):635-50
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [The pre-operative assessment of bronchial carcinoma. The surgeon's viewpoint].
  • [Transliterated title] Le bilan préopératoire du cancer bronchique. Le point de vue du chirurgien.
  • INTRODUCTION: The overall prognosis of non-small cell carcinoma of the bronchus (NSCLC) remains poor on account of frequently late diagnosis and associated co-morbidity preventing the optimal treatment of the tumour.
  • Surgical resection remains the best curative treatment for limited stage disease.
  • [MeSH-major] Carcinoma, Non-Small-Cell Lung / diagnosis. Carcinoma, Non-Small-Cell Lung / surgery. Lung Neoplasms / diagnosis. Lung Neoplasms / surgery. Preoperative Care
  • [MeSH-minor] Humans. Neoplasm Staging. Risk Assessment

  • MedlinePlus Health Information. consumer health - Lung Cancer.
  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16294182.001).
  • [ISSN] 0761-8425
  • [Journal-full-title] Revue des maladies respiratoires
  • [ISO-abbreviation] Rev Mal Respir
  • [Language] fre
  • [Publication-type] English Abstract; Journal Article; Review
  • [Publication-country] France
  • [Number-of-references] 97
  •  go-up   go-down


42. Bellamy J: [Conservative management of the phrenic nerve and surgical treatment of lung cancer]. Rev Pneumol Clin; 2010 Jun;66(3):167-72
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Conservative management of the phrenic nerve and surgical treatment of lung cancer].
  • [Transliterated title] La préservation du nerf phrénique dans la chirurgie du cancer bronchique.
  • Bronchial carcinoma may involve the phrenic nerve, confronting the surgeon with a difficult choice.
  • In 10 patients undergoing surgery for bronchial carcinoma without previous diaphragmatic palsy, extension to the nerve was discovered during the thoracotomy, leading to a choice between radical surgery involving resection of the nerve, with subsequent diaphragmatic palsy, or incomplete conservative resection preserving the lung function.
  • [MeSH-major] Carcinoma, Bronchogenic / surgery. Lung Neoplasms / surgery. Phrenic Nerve. Pneumonectomy / methods

  • Genetic Alliance. consumer health - Lung Cancer.
  • MedlinePlus Health Information. consumer health - Lung Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] Copyright 2009 Elsevier Masson SAS. All rights reserved.
  • (PMID = 20561481.001).
  • [ISSN] 0761-8417
  • [Journal-full-title] Revue de pneumologie clinique
  • [ISO-abbreviation] Rev Pneumol Clin
  • [Language] fre
  • [Publication-type] English Abstract; Journal Article
  • [Publication-country] France
  •  go-up   go-down


43. Lemarié E: [Stage IV non small cell bronchial carcinoma; first line therapy in 2007]. Rev Mal Respir; 2007 Oct;24(8 Pt 2):6S101-7
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Stage IV non small cell bronchial carcinoma; first line therapy in 2007].
  • [Transliterated title] Cancer bronchique non à petites cellules de stade IV : la première ligne en 2007.
  • Lung cancer is the leading cause of cancer related deaths throughout the world, with a 5 year survival rate of 15%.
  • For advanced stage non-small cell lung cancer chemotherapy prolongs survival and improves quality of life in patients with good performance status.
  • [MeSH-major] Antineoplastic Agents / therapeutic use. Carcinoma, Non-Small-Cell Lung / drug therapy. Lung Neoplasms / drug therapy
  • [MeSH-minor] Humans. Neoplasm Metastasis

  • MedlinePlus Health Information. consumer health - Cancer Chemotherapy.
  • MedlinePlus Health Information. consumer health - Lung Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18235401.001).
  • [ISSN] 0761-8425
  • [Journal-full-title] Revue des maladies respiratoires
  • [ISO-abbreviation] Rev Mal Respir
  • [Language] fre
  • [Publication-type] English Abstract; Journal Article; Review
  • [Publication-country] France
  • [Chemical-registry-number] 0 / Antineoplastic Agents
  • [Number-of-references] 40
  •  go-up   go-down


44. O'Flaherty MT, Thompson NW, Ellis PK, Barr RJ: Full-length radiographs of the femur in patients with a femoral neck fracture and co-existent malignancy--are they of benefit? Ulster Med J; 2008 Sep;77(3):181-4
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Over a two-year period, we identified 133 (47 males, 86 females) patients admitted with a femoral neck fracture and a co-existent history of malignant disease, representing 6.5% of all femoral neck fractures admitted within this time frame.
  • Overall, breast (35%), lower gastrointestinal (22%), prostatic (18%) and bronchogenic carcinomas (7%) were the most common associated malignancies.
  • Furthermore, none of the patients to date have required readmission with a secondary fracture relating to disease in the middle or distal thirds of their femur.
  • We conclude that full-length views of the femur are of limited value in patients presenting with a femoral neck fracture and a co-existent history of malignant disease.

  • MedlinePlus Health Information. consumer health - Bone Cancer.
  • MedlinePlus Health Information. consumer health - Hip Injuries and Disorders.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Bone. 2001 Dec;29(6):517-22 [11728921.001]
  • [Cites] Int Orthop. 2001;25(6):349-54 [11820439.001]
  • [Cites] J Bone Joint Surg Am. 2002 Aug;84-A(8):1342-8 [12177263.001]
  • [Cites] Br J Surg. 1969 Oct;56(10):757-64 [5354800.001]
  • [Cites] Semin Nucl Med. 1984 Oct;14(4):277-86 [6387915.001]
  • [Cites] Injury. 2005 May;36(5):622-6 [15826621.001]
  • [Cites] Clin Orthop Relat Res. 1990 Nov;(260):220-3 [1699694.001]
  • [Cites] J Bone Joint Surg Am. 1997 Jun;79(6):917-32 [9199392.001]
  • [Cites] Am J Med. 1997 Aug 18;103(2A):51S-63S; discussion 63S-64S [9302897.001]
  • [Cites] J Bone Joint Surg Br. 1999 Jan;81(1):1-2 [10067992.001]
  • [Cites] Br J Anaesth. 2005 Jan;94(1):24-9 [15516350.001]
  • [Cites] Clin Orthop Relat Res. 1986 Sep;(210):18-30 [3757360.001]
  • (PMID = 18956800.001).
  • [ISSN] 0041-6193
  • [Journal-full-title] The Ulster medical journal
  • [ISO-abbreviation] Ulster Med J
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] Northern Ireland
  • [Other-IDs] NLM/ PMC2604475
  •  go-up   go-down


45. Peñalver Cuesta JC, Jordá Aragón C, Escrivá Peiró J, Cerón Navarro J, Calvo Medina V, Padilla Alarcón J: [Lung transplantation: bronchogenic carcinoma in the native lung]. Arch Bronconeumol; 2007 Feb;43(2):126-8
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Lung transplantation: bronchogenic carcinoma in the native lung].
  • [Transliterated title] Trasplante pulmonar. Carcinoma broncogénico en pulmón nativo.
  • In lung transplantation, the presence of bronchogenic carcinoma in the native organ is uncommon, but doubtless affects patient survival, independently of the transplantation process itself.
  • We describe 2 cases in which a primary tumor was found in the explanted lung--1 case of adenocarcinoma in a patient with pulmonary emphysema and 1 case of bronchioloalveolar carcinoma in a patient with idiopathic pulmonary fibrosis.
  • Both patients died due to the recurrence of the neoplastic disease.
  • [MeSH-major] Adenocarcinoma / etiology. Carcinoma, Bronchogenic / etiology. Lung Neoplasms / etiology. Lung Transplantation / adverse effects

  • Genetic Alliance. consumer health - Transplantation.
  • MedlinePlus Health Information. consumer health - Lung Cancer.
  • MedlinePlus Health Information. consumer health - Lung Transplantation.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17288900.001).
  • [ISSN] 0300-2896
  • [Journal-full-title] Archivos de bronconeumología
  • [ISO-abbreviation] Arch. Bronconeumol.
  • [Language] spa
  • [Publication-type] Case Reports; English Abstract; Journal Article
  • [Publication-country] Spain
  •  go-up   go-down


46. Malta DC, Moura Ld, Souza Mde F, Curado MP, Alencar AP, Alencar GP: Lung cancer, cancer of the trachea, and bronchial cancer: mortality trends in Brazil, 1980-2003. J Bras Pneumol; 2007 Sep-Oct;33(5):536-43
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Lung cancer, cancer of the trachea, and bronchial cancer: mortality trends in Brazil, 1980-2003.
  • OBJECTIVE: To describe the mortality trends for lung cancer, cancer of the trachea, and bronchial cancer in relation to gender and age brackets in Brazil.
  • RESULTS: In Brazil, the standardized mortality rate for lung cancer, cancer of the trachea, and bronchial cancer increased from 7.21/100,000 inhabitants in 1980 to 9.36/100,000 inhabitants in 2003.
  • [MeSH-major] Bronchial Neoplasms / mortality. Lung Neoplasms / mortality. Tracheal Neoplasms / mortality

  • Genetic Alliance. consumer health - Lung Cancer.
  • MedlinePlus Health Information. consumer health - Lung Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18026651.001).
  • [ISSN] 1806-3756
  • [Journal-full-title] Jornal brasileiro de pneumologia : publicaça̋o oficial da Sociedade Brasileira de Pneumologia e Tisilogia
  • [ISO-abbreviation] J Bras Pneumol
  • [Language] eng; por
  • [Publication-type] Journal Article
  • [Publication-country] Brazil
  •  go-up   go-down


47. LeCaer H, Fournel P, Jullian H, Chouaid C, Letreut J, Thomas P, Paillotin D, Perol M, Gimenez C, Vergnenegre A: An open multicenter phase II trial of docetaxel-gemcitabine in Charlson score and performance status (PS) selected elderly patients with stage IIIB pleura/IV non-small-cell lung cancer (NSCLC): the GFPC 02-02a study. Crit Rev Oncol Hematol; 2007 Oct;64(1):73-81
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] An open multicenter phase II trial of docetaxel-gemcitabine in Charlson score and performance status (PS) selected elderly patients with stage IIIB pleura/IV non-small-cell lung cancer (NSCLC): the GFPC 02-02a study.
  • The aim of this study was to determine the impact of patient selection based on age, comorbidity and performance status on the efficacy of platinum-free combination therapy on non-small-cell lung cancer after 65 years of age.
  • Lung cancer and aging. ASCO 2005.
  • Primary bronchial carcinoma in elderly subjects in France.
  • Should elderly non-small-cell lung cancer patients be offered elderly-specific trials?
  • Results of a pooled analysis from the North Central Cancer Treatment Group.
  • Management of cancer in the older person: a practical approach.
  • Forty-five patients were assessable: 17 (34%) had an objective response, 18 (36%) had stable disease and 10 progressed (20%).
  • [MeSH-major] Carcinoma, Non-Small-Cell Lung / drug therapy. Deoxycytidine / analogs & derivatives. Patient Selection. Pleural Neoplasms / drug therapy. Taxoids / administration & dosage
  • [MeSH-minor] Age Factors. Antimetabolites, Antineoplastic. Antineoplastic Combined Chemotherapy Protocols. Comorbidity. Humans. Neoplasm Staging. Severity of Illness Index. Treatment Outcome

  • Genetic Alliance. consumer health - Lung Cancer.
  • Genetic Alliance. consumer health - Non-small cell lung cancer.
  • Hazardous Substances Data Bank. DOCETAXEL .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17669664.001).
  • [ISSN] 1040-8428
  • [Journal-full-title] Critical reviews in oncology/hematology
  • [ISO-abbreviation] Crit. Rev. Oncol. Hematol.
  • [Language] eng
  • [Publication-type] Clinical Trial, Phase II; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't
  • [Publication-country] Ireland
  • [Chemical-registry-number] 0 / Antimetabolites, Antineoplastic; 0 / Taxoids; 0W860991D6 / Deoxycytidine; 15H5577CQD / docetaxel; B76N6SBZ8R / gemcitabine
  •  go-up   go-down


48. Armentia A, Bartolomé B, Puyo M, Paredes C, Calderón S, Asensio T, del Villar V: Tobacco as an allergen in bronchial disease. Ann Allergy Asthma Immunol; 2007 Apr;98(4):329-36
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Tobacco as an allergen in bronchial disease.
  • OBJECTIVE: To verify if a specific clinical allergenic response against tobacco might be possible in allergenic and nonallergenic bronchial diseases.
  • METHODS: We performed a cross-sectional observational case-control analysis on 180 patients with asthma, chronic obstructive pulmonary disease (COPD), and bronchial carcinoma and controls who were randomly chosen.
  • Skin prick tests and serum specific IgE to tobacco and related allergens, bronchial challenge with cigarettes and tobacco extract, patch tests with tobacco and nicotine, sodium dodecyl sulfate-polyacrylamide gel electrophoresis immunoblotting, and Enzyme AllergoSorbent Test (EAST) inhibition were performed.
  • The association among positive skin prick test results, IgE, and bronchial challenge was strong (P < .001).
  • Tobacco sensitivity was higher in patients with pollen asthma than in patients with COPD and carcinoma and negative in patients with intrinsic asthma and controls.
  • A positive bronchial challenge result was related to the length of habit (P < .001) and the tobacco index in patients who had stopped smoking (P < .001).
  • Delayed bronchial and patch response was more common in patients with COPD (P < .001).
  • [MeSH-major] Allergens. Asthma / immunology. Bronchial Neoplasms / immunology. Tobacco / immunology
  • [MeSH-minor] Adolescent. Adult. Bronchial Provocation Tests. Case-Control Studies. Cross Reactions. Cross-Sectional Studies. Female. Humans. Immunoglobulin E / blood. Immunoglobulin E / immunology. Male. Middle Aged. Pollen. Pulmonary Disease, Chronic Obstructive / blood. Pulmonary Disease, Chronic Obstructive / immunology. Skin Tests

  • MedlinePlus Health Information. consumer health - Asthma.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17458428.001).
  • [ISSN] 1081-1206
  • [Journal-full-title] Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology
  • [ISO-abbreviation] Ann. Allergy Asthma Immunol.
  • [Language] eng
  • [Publication-type] Comparative Study; Journal Article; Randomized Controlled Trial
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Allergens; 37341-29-0 / Immunoglobulin E
  •  go-up   go-down


49. Serke M: [Pharmacologic treatment of bronchial cancer. Part 1: Standards]. Pneumologie; 2006 Aug;60(8):493-508
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Pharmacologic treatment of bronchial cancer. Part 1: Standards].
  • [Transliterated title] Pharmakologische Therapie des Bronchialkarzinom. Teil I: Standards.
  • In the last decade there have been important innovations in the treatment of lung tumors.
  • New therapeutic agents are under investigation that will hopefully improve the outcome of small cell lung cancer (SCLC) and non-small cell lung cancer (NSCLC).
  • Principles of chemotherapy in non-small cell und small cell lung cancer depending on stage and combination in multimodal regimens are shown.
  • [MeSH-major] Antineoplastic Agents / standards. Antineoplastic Agents / therapeutic use. Carcinoma, Bronchogenic / drug therapy. Lung Neoplasms / drug therapy
  • [MeSH-minor] Antineoplastic Combined Chemotherapy Protocols / standards. Antineoplastic Combined Chemotherapy Protocols / therapeutic use. Carcinoma, Non-Small-Cell Lung / drug therapy. Carcinoma, Small Cell / drug therapy. Humans. Quality Assurance, Health Care

  • MedlinePlus Health Information. consumer health - Cancer Chemotherapy.
  • MedlinePlus Health Information. consumer health - Lung Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16933193.001).
  • [ISSN] 0934-8387
  • [Journal-full-title] Pneumologie (Stuttgart, Germany)
  • [ISO-abbreviation] Pneumologie
  • [Language] ger
  • [Publication-type] English Abstract; Journal Article
  • [Publication-country] Germany
  • [Chemical-registry-number] 0 / Antineoplastic Agents
  •  go-up   go-down


50. Li J, Ghio AJ, Cho SH, Brinckerhoff CE, Simon SA, Liedtke W: Diesel exhaust particles activate the matrix-metalloproteinase-1 gene in human bronchial epithelia in a beta-arrestin-dependent manner via activation of RAS. Environ Health Perspect; 2009 Mar;117(3):400-9
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Diesel exhaust particles activate the matrix-metalloproteinase-1 gene in human bronchial epithelia in a beta-arrestin-dependent manner via activation of RAS.
  • Matrix metalloproteinase-1 (MMP-1) has been implied as an (etio)pathogenic factor in human lung and airway diseases such as emphysema, chronic obstructive pulmonary disease, chronic asthma, tuberculosis, and bronchial carcinoma and has been reported to be regulated by DEPs.
  • METHODS/RESULTS: Using permanent and primary human bronchial epithelial (HBE) cells at air-liquid interface, we show that DEPs activate the human MMP-1 gene via RAS and subsequent activation of RAF-MEK-ERK1/2 mitogen-activated protein kinase signaling, which can be scaffolded by beta-arrestins.

  • COS Scholar Universe. author profiles.
  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .
  • NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .
  • The Lens. Cited by Patents in .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] COPD. 2004 Apr;1(1):13-23 [16997735.001]
  • [Cites] J Hepatol. 2007 Jan;46(1):124-33 [17030072.001]
  • [Cites] Toxicol Appl Pharmacol. 2003 Oct 1;192(1):21-35 [14554100.001]
  • [Cites] Breast Cancer Res Treat. 2003 Nov;82(2):75-82 [14692651.001]
  • [Cites] Am J Physiol Lung Cell Mol Physiol. 2004 Feb;286(2):L427-36 [14565943.001]
  • [Cites] J Biol Chem. 2004 Apr 23;279(17):17690-6 [14764579.001]
  • [Cites] Environ Health Perspect. 2004 Jun;112(8):820-5 [15175167.001]
  • [Cites] Int J Biochem Cell Biol. 2005 Feb;37(2):283-8 [15474975.001]
  • [Cites] Int J Biochem Cell Biol. 2005 Feb;37(2):375-85 [15474982.001]
  • [Cites] J Appl Toxicol. 1985 Oct;5(5):295-300 [2414356.001]
  • [Cites] Postgrad Med. 1985 Nov 1;78(6):199-201, 204-7 [2414766.001]
  • [Cites] Annu Rev Pharmacol Toxicol. 1987;27:279-300 [2437855.001]
  • [Cites] Differentiation. 1988 Jun;38(1):60-6 [2846394.001]
  • [Cites] Science. 1990 Jun 22;248(4962):1547-50 [2163110.001]
  • [Cites] Environ Health Perspect. 1994 Oct;102 Suppl 4:187-92 [7529702.001]
  • [Cites] Fundam Appl Toxicol. 1995 Apr;25(1):80-94 [7541380.001]
  • [Cites] Exp Lung Res. 1998 Jan-Feb;24(1):85-100 [9457471.001]
  • [Cites] Am J Respir Cell Mol Biol. 1998 Mar;18(3):441-8 [9490663.001]
  • [Cites] Cancer Res. 1998 Dec 1;58(23):5321-5 [9850057.001]
  • [Cites] FEBS Lett. 2005 Jan 3;579(1):173-8 [15620709.001]
  • [Cites] Cell. 2005 Feb 11;120(3):303-13 [15707890.001]
  • [Cites] Mol Cancer Ther. 2005 Apr;4(4):677-85 [15827342.001]
  • [Cites] Cell Signal. 2005 Oct;17(10):1248-53 [16038799.001]
  • [Cites] J Biol Chem. 2005 Sep 16;280(37):32157-67 [16027114.001]
  • [Cites] Inhal Toxicol. 2005 Dec 1;17(13):709-16 [16195206.001]
  • [Cites] Rheumatology (Oxford). 2005 Nov;44(11):1383-9 [16049050.001]
  • [Cites] Am J Respir Crit Care Med. 2005 Dec 15;172(12):1596-604 [16141443.001]
  • [Cites] Nat Neurosci. 2006 Feb;9(2):283-91 [16429133.001]
  • [Cites] Eur Respir J. 2006 Apr;27(4):705-13 [16455839.001]
  • [Cites] Am J Physiol Lung Cell Mol Physiol. 2006 Aug;291(2):L272-80 [16510471.001]
  • [Cites] J Clin Invest. 2006 Aug;116(8):2208-2217 [16862215.001]
  • [Cites] Proc Am Thorac Soc. 2006 Aug;3(6):477 [16921115.001]
  • [Cites] Cancer Res. 2006 Sep 1;66(17):8722-30 [16951188.001]
  • [Cites] Am J Epidemiol. 2007 Jan 1;165(1):53-62 [17062632.001]
  • [Cites] Am J Physiol Lung Cell Mol Physiol. 2007 Feb;292(2):L422-9 [17028263.001]
  • [Cites] Annu Rev Physiol. 2007;69:483-510 [17305471.001]
  • [Cites] Oncogene. 2007 May 14;26(22):3291-310 [17496923.001]
  • [Cites] J Biol Chem. 2007 Jun 29;282(26):18722-31 [17475625.001]
  • [Cites] Am J Physiol Lung Cell Mol Physiol. 2007 Jul;293(1):L170-81 [17449795.001]
  • [Cites] Am J Respir Cell Mol Biol. 2007 Aug;37(2):232-9 [17395887.001]
  • [Cites] Br J Haematol. 2007 Aug;138(4):446-58 [17593251.001]
  • [Cites] Mol Cancer Ther. 2007 Sep;6(9):2449-57 [17766837.001]
  • [Cites] Cancer Lett. 2000 Feb 28;149(1-2):195-202 [10737724.001]
  • [Cites] Toxicol Pathol. 2000 Jul-Aug;28(4):619-27 [10930050.001]
  • [Cites] Toxicol Appl Pharmacol. 2000 Oct 15;168(2):140-8 [11032769.001]
  • [Cites] Science. 2000 Nov 24;290(5496):1574-7 [11090355.001]
  • [Cites] Oncol Rep. 2001 Mar-Apr;8(2):421-4 [11182067.001]
  • [Cites] Eur Respir J. 2001 Apr;17(4):733-46 [11401072.001]
  • [Cites] J Biol Chem. 1999 Dec 10;274(50):35297-300 [10585392.001]
  • [Cites] Chest. 2000 Mar;117(3):684-94 [10712992.001]
  • [Cites] Nat Rev Mol Cell Biol. 2002 Mar;3(3):207-14 [11994741.001]
  • [Cites] Biochim Biophys Acta. 2002 Apr 24;1586(3):265-74 [11997078.001]
  • [Cites] Int J Cancer. 2003 Jan 10;103(2):161-8 [12455029.001]
  • [Cites] Am J Physiol Lung Cell Mol Physiol. 2003 Jan;284(1):L119-32 [12471014.001]
  • [Cites] Proc Natl Acad Sci U S A. 2003 Feb 18;100(4):1740-4 [12582207.001]
  • [Cites] Toxicology. 2003 May 3;187(2-3):161-70 [12699905.001]
  • [Cites] J Clin Invest. 2003 Aug;112(4):566-74 [12925697.001]
  • [Cites] Int J Chron Obstruct Pulmon Dis. 2006;1(2):137-50 [18046891.001]
  • [Cites] Int J Biochem Cell Biol. 2008;40(3):432-46 [17936667.001]
  • [Cites] Proc Am Thorac Soc. 2008 Jul 15;5(5):577-90 [18625750.001]
  • [Cites] Am J Respir Cell Mol Biol. 2009 Jan;40(1):4-12 [18617682.001]
  • [Cites] J Biol Chem. 2002 Feb 22;277(8):6296-302 [11741975.001]
  • [ErratumIn] Environ Health Perspect. 2009 Apr;117(4):A143
  • (PMID = 19337515.001).
  • [ISSN] 1552-9924
  • [Journal-full-title] Environmental health perspectives
  • [ISO-abbreviation] Environ. Health Perspect.
  • [Language] ENG
  • [Grant] United States / NCI NIH HHS / CA / CA-77267; United States / NCI NIH HHS / CA / R01 CA077267; United States / NIAMS NIH HHS / AR / AR-26599; United States / NIAMS NIH HHS / AR / R01 AR026599; United States / NIAMS NIH HHS / AR / R37 AR026599
  • [Publication-type] Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S.
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Arrestins; 0 / DNA Primers; 0 / Vehicle Emissions; 0 / beta-arrestin; EC 3.4.24.7 / Matrix Metalloproteinase 1; EC 3.6.5.2 / ras Proteins
  • [Other-IDs] NLM/ PMC2661910
  • [Keywords] NOTNLM ; MAP kinase / MMP-1 / MMP-1 promoter polymorphism / bronchial epithelia / diesel particles / urban smog / β-arrestin
  •  go-up   go-down


51. Cudennec T, Gendry T, Labrune S, Giraud V, Moulias S, Teillet L, Chinet T: Use of a simplified geriatric evaluation in thoracic oncology. Lung Cancer; 2010 Feb;67(2):232-6
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Management of elderly patients with bronchial cancer should take into account specific factors linked to the patient's age, and the presence of co-morbidities.
  • We describe the use of a simplified geriatric evaluation (SGE), in 57 patients aged >/=75 years (mean age: 80.8 years) with thoracic cancer, before discussing therapeutic options with colleagues from various departments.
  • These data suggest that the SGE is an important aid to decision-making in the management of elderly patients with bronchial cancer.
  • [MeSH-major] Geriatric Assessment / methods. Health Status Indicators. Lung Neoplasms / classification

  • MedlinePlus Health Information. consumer health - Lung Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] Copyright 2009 Elsevier Ireland Ltd. All rights reserved.
  • (PMID = 19427054.001).
  • [ISSN] 1872-8332
  • [Journal-full-title] Lung cancer (Amsterdam, Netherlands)
  • [ISO-abbreviation] Lung Cancer
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] Ireland
  •  go-up   go-down


52. Capkova L, Kalinova M, Krskova L, Kodetova D, Petrik F, Trefny M, Musil J, Kodet R: Loss of heterozygosity and human telomerase reverse transcriptase (hTERT) expression in bronchial mucosa of heavy smokers. Cancer; 2007 Jun 1;109(11):2299-307
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Loss of heterozygosity and human telomerase reverse transcriptase (hTERT) expression in bronchial mucosa of heavy smokers.
  • BACKGROUND: Lung carcinogenesis is a multistep process of accumulation of genetic changes, including loss of heterozygosity (LOH), and precedes phenotypic transformation of the bronchial mucosa.
  • In this study, the frequency of LOH and hTERT expression in bronchial mucosa of heavy smokers in bronchoscopic biopsies was analyzed.
  • METHODS: LOH was examined in 122 bronchial specimens from 81 smokers (67 normal mucosa/bronchitis, 12 squamous metaplasia, 28 dysplasia, 15 bronchogenic carcinoma specimens) by polymerase chain reaction (PCR) and capillary electrophoresis by using 7 fluorescence-labeled markers matching 5 chromosomal regions. hTERT expression was analyzed in 87 specimens (45 normal mucosa/bronchitis, 12 squamous metaplasia, 18 dysplasia, 12 bronchogenic carcinoma specimens) by real-time quantitative reverse-transcription PCR.
  • RESULTS: LOH was detected in at least 1 chromosomal region in 51 of 122 (41.8%) specimens; the incidence in normal bronchial mucosa and preneoplastic lesions was similar (20%-40%); a substantial rise (87%) occurred in carcinomas.
  • The median normalized hTERT(N) values were 6.67 in normal epithelium/chronic bronchitis, 18.38 in squamous metaplasia, 13.31 in epithelial dysplasia, and 75.46 in carcinomas.
  • CONCLUSIONS: Results indicated that hTERT expression, together with LOH, represent early events in lung carcinogenesis, as both were detected in precancerous lesions and in normal epithelium of heavy smokers.
  • [MeSH-major] Carcinoma, Bronchogenic / genetics. Loss of Heterozygosity. Lung Neoplasms / genetics. Smoking / genetics. Telomerase / genetics
  • [MeSH-minor] Bronchi / metabolism. Bronchi / pathology. Epithelial Cells / metabolism. Epithelial Cells / pathology. Female. Humans. Male. Metaplasia. Mucous Membrane / metabolism. Mucous Membrane / pathology. Precancerous Conditions / metabolism. Precancerous Conditions / pathology. RNA, Messenger / metabolism. Reverse Transcriptase Polymerase Chain Reaction

  • MedlinePlus Health Information. consumer health - Lung Cancer.
  • MedlinePlus Health Information. consumer health - Smoking.
  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17429837.001).
  • [ISSN] 0008-543X
  • [Journal-full-title] Cancer
  • [ISO-abbreviation] Cancer
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / RNA, Messenger; EC 2.7.7.49 / TERT protein, human; EC 2.7.7.49 / Telomerase
  •  go-up   go-down


53. Khan AN, Al-Jahdali HH, Allen CM, Irion KL, Al Ghanem S, Koteyar SS: The calcified lung nodule: What does it mean? Ann Thorac Med; 2010 Apr;5(2):67-79
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] The calcified lung nodule: What does it mean?
  • The aim of this review is to present a pictorial essay emphasizing the various patterns of calcification in pulmonary nodules (PN) to aid diagnosis and to discuss the differential diagnosis and the pathogenesis where it is known.
  • The imaging evaluation of PN is based on clinical history, size, distribution and the gross appearance of the nodule as well as feasibility of obtaining a tissue diagnosis.
  • Imaging is instrumental in the management of PN and one should strive not only to identify small malignant tumors with high survival rates but to spare patients with benign PN from undergoing unnecessary surgery.
  • Calcification in PN is generally considered as a pointer toward a possible benign disease.
  • The differential considerations of a calcified lesion include calcified granuloma, hamartoma, carcinoid, osteosarcoma, chondrosarcoma and lung metastases or a primary bronchogenic carcinoma among others.

  • NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] J Chin Med Assoc. 2004 Jan;67(1):21-6 [15077886.001]
  • [Cites] Nihon Igaku Hoshasen Gakkai Zasshi. 2004 Jul;64(5):300-4 [15377049.001]
  • [Cites] AJR Am J Roentgenol. 2005 Jan;184(1):273-82 [15615988.001]
  • [Cites] Indian J Pathol Microbiol. 2008 Jan-Mar;51(1):61-2 [18417859.001]
  • [Cites] Diagn Cytopathol. 2008 May;36(5):331-2 [18418855.001]
  • [Cites] Acta Cytol. 2008 May-Jun;52(3):357-60 [18540306.001]
  • [Cites] J Exp Clin Cancer Res. 2008;27:8 [18577258.001]
  • [Cites] Acta Cytol. 2008 Jul-Aug;52(4):412-7 [18702357.001]
  • [Cites] Ann Thorac Surg. 2008 Dec;86(6):1769-72 [19021972.001]
  • [Cites] J Comput Assist Tomogr. 2008 Nov-Dec;32(6):919-25 [19204455.001]
  • [Cites] AJR Am J Roentgenol. 1977 Jun;128(6):893-914 [414553.001]
  • [Cites] Ann Intern Med. 1979 Mar;90(3):324-8 [426400.001]
  • [Cites] Br J Dis Chest. 1979 Jan;73(1):71-80 [435380.001]
  • [Cites] Radiat Environ Biophys. 1978 Oct 12;15(3):241-59 [746119.001]
  • [Cites] J Thorac Imaging. 1992 Sep;7(4):29-38 [1404543.001]
  • [Cites] J Thorac Imaging. 1992 Sep;7(4):39-50 [1404544.001]
  • [Cites] Radiographics. 1992 May;12(3):505-14 [1609141.001]
  • [Cites] Radiology. 1991 May;179(2):483-6 [2014296.001]
  • [Cites] AJR Am J Roentgenol. 1990 Apr;154(4):701-8 [2107661.001]
  • [Cites] AJR Am J Roentgenol. 1990 Feb;154(2):255-8 [2153329.001]
  • [Cites] Can Assoc Radiol J. 1990 Aug;41(4):217-8 [2169970.001]
  • [Cites] Radiol Clin North Am. 1990 May;28(3):511-20 [2183261.001]
  • [Cites] AJR Am J Roentgenol. 1986 May;146(5):997-1004 [3008544.001]
  • [Cites] Can Assoc Radiol J. 1988 Dec;39(4):290-2 [3203225.001]
  • [Cites] Radiology. 1986 Aug;160(2):307-12 [3726105.001]
  • [Cites] Radiology. 1986 Aug;160(2):313-7 [3726106.001]
  • [Cites] Radiology. 1986 Aug;160(2):319-27 [3726107.001]
  • [Cites] Chest. 1987 Jan;91(1):128-33 [3792065.001]
  • [Cites] J Comput Assist Tomogr. 1985 Jan-Feb;9(1):180-2 [3881488.001]
  • [Cites] Am J Med. 1985 May;78(5):881-4 [3993669.001]
  • [Cites] J Thorac Cardiovasc Surg. 1967 Apr;53(4):457-66 [6022399.001]
  • [Cites] J Thorac Cardiovasc Surg. 1967 May;53(5):735-42 [6025818.001]
  • [Cites] Radiology. 1984 Mar;150(3):785-6 [6695080.001]
  • [Cites] Br J Radiol. 1982 Feb;55(650):108-13 [7055656.001]
  • [Cites] J Clin Invest. 1980 Oct;66(4):852-5 [7419722.001]
  • [Cites] Radiographics. 1994 Nov;14(6):1247-61 [7855339.001]
  • [Cites] J Comput Assist Tomogr. 1994 Nov-Dec;18(6):867-71 [7962791.001]
  • [Cites] AJR Am J Roentgenol. 1994 Apr;162(4):799-802 [8140993.001]
  • [Cites] J Comput Assist Tomogr. 1994 May-Jun;18(3):497-9 [8188924.001]
  • [Cites] Radiographics. 1993 Nov;13(6):1295-308 [8290725.001]
  • [Cites] Radiology. 1993 Jun;187(3):689-93 [8388567.001]
  • [Cites] Pediatr Radiol. 1996;26(1):19-21 [8598988.001]
  • [Cites] Am J Clin Pathol. 1996 Feb;105(2):189-94 [8607443.001]
  • [Cites] Radiology. 1996 May;199(2):297-306 [8668768.001]
  • [Cites] Eur J Med Res. 1996 May 24;1(8):371-6 [9360936.001]
  • [Cites] Radiographics. 1998 Mar-Apr;18(2):311-20; discussion 320-3 [9536480.001]
  • [Cites] J Thorac Imaging. 1999 Jul;14(3):218-20 [10404510.001]
  • [Cites] AJR Am J Roentgenol. 2000 Mar;174(3):789-93 [10701626.001]
  • [Cites] Eur J Radiol. 2005 May;54(2):233-45 [15837404.001]
  • [Cites] J Med Assoc Thai. 2006 Feb;89(2):190-5 [16579005.001]
  • [Cites] Cytopathology. 2008 Jun;19(3):185-91 [17388933.001]
  • [Cites] Am J Med. 1969 Feb;46(2):188-96 [5775001.001]
  • [Cites] Semin Diagn Pathol. 2007 Aug;24(3):199-208 [17882903.001]
  • [Cites] J Thorac Oncol. 2007 Oct;2(10):983-4 [17909365.001]
  • [Cites] Am J Surg Pathol. 2007 Dec;31(12):1844-53 [18043038.001]
  • [Cites] Korean J Radiol. 2008 Mar-Apr;9(2):186-9 [18385568.001]
  • [Cites] Respir Med. 2000 Mar;94(3):190-3 [10783928.001]
  • [Cites] AJR Am J Roentgenol. 2000 Oct;175(4):1019-24 [11000156.001]
  • [Cites] J Comput Assist Tomogr. 2000 Sep-Oct;24(5):691-8 [11045687.001]
  • [Cites] Respir Med. 2001 Mar;95(3):187-90 [11266235.001]
  • [Cites] Radiographics. 2002 May-Jun;22(3):621-37 [12006691.001]
  • [Cites] Am J Respir Crit Care Med. 2002 Jun 15;165(12):1654-69 [12070068.001]
  • [Cites] Radiographics. 2002 Oct;22 Spec No:S61-78 [12376601.001]
  • [Cites] Jpn J Clin Oncol. 2003 Jan;33(1):10-3 [12604717.001]
  • [Cites] N Engl J Med. 2003 Jun 19;348(25):2535-42 [12815140.001]
  • [Cites] N Engl J Med. 1955 Jul 28;253(4):135-7 [14394343.001]
  • [Cites] J Thorac Imaging. 2004 Apr;19(2):98-102 [15071327.001]
  • (PMID = 20582171.001).
  • [ISSN] 1998-3557
  • [Journal-full-title] Annals of thoracic medicine
  • [ISO-abbreviation] Ann Thorac Med
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] India
  • [Other-IDs] NLM/ PMC2883201
  • [Keywords] NOTNLM ; Benign pulmonary nodules / calcification / malignant pulmonary nodules
  •  go-up   go-down


54. Ross P Jr, Grecula J, Bekaii-Saab T, Villalona-Calero M, Otterson G, Magro C: Incorporation of photodynamic therapy as an induction modality in non-small cell lung cancer. Lasers Surg Med; 2006 Dec;38(10):881-9
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Incorporation of photodynamic therapy as an induction modality in non-small cell lung cancer.
  • BACKGROUND AND OBJECTIVES: Incorporation of photodynamic therapy (PDT) into the induction therapy regimen utilized for treatment of locally advanced primary non-small cell bronchogenic carcinoma (NSCLC) is explored.
  • [MeSH-major] Carcinoma, Non-Small-Cell Lung / drug therapy. Hematoporphyrins / therapeutic use. Lung Neoplasms / drug therapy. Photochemotherapy. Photosensitizing Agents / therapeutic use
  • [MeSH-minor] Adult. Aged. Aged, 80 and over. Combined Modality Therapy. Female. Humans. Male. Middle Aged. Neoplasm Recurrence, Local. Pneumonectomy. Postoperative Complications. Retrospective Studies. Survival Analysis. Treatment Outcome

  • Genetic Alliance. consumer health - Lung Cancer.
  • Genetic Alliance. consumer health - Non-small cell lung cancer.
  • MedlinePlus Health Information. consumer health - Lung Cancer.
  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] (c) 2006 Wiley-Liss, Inc.
  • (PMID = 17115382.001).
  • [ISSN] 0196-8092
  • [Journal-full-title] Lasers in surgery and medicine
  • [ISO-abbreviation] Lasers Surg Med
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Hematoporphyrins; 0 / Photosensitizing Agents
  •  go-up   go-down


55. Sharma V, Sharma NL, Ranjan N, Tegta GR, Sarin S: Acrokeratosis paraneoplastica (Bazex syndrome): case report and review of literature. Dermatol Online J; 2006;12(1):11
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • This syndrome is important because the cutaneous findings preceed the onset of symptoms referable to the underlying neoplasm by several months in majority of the cases.
  • We report here a case of a 63-year-old cachectic female who had classic psoriasiform lesions of acrokeratosis of Bazex with underlying bronchogenic carcinoma of the right lung.
  • [MeSH-minor] Carcinoma, Bronchogenic / radiography. Female. Humans. Lung Neoplasms / radiography. Lymphatic Metastasis / radiography. Middle Aged. Tomography, X-Ray Computed

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16638379.001).
  • [ISSN] 1087-2108
  • [Journal-full-title] Dermatology online journal
  • [ISO-abbreviation] Dermatol. Online J.
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article; Review
  • [Publication-country] United States
  • [Number-of-references] 7
  •  go-up   go-down


56. Shamim MS, Bari ME, Enam SA: Dural metastases presenting as an extradural hematoma: a rare presentation. J Pak Med Assoc; 2005 Nov;55(11):509-10
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • This patient was later found to have dural metastases secondary to bronchogenic carcinoma.
  • Dural metastases are rare, usually presenting as dural mass, but may also present as chronic subdural or extradural hematoma on non contrast CT scan, leading to an erroneous diagnosis in the unsuspecting.
  • [MeSH-major] Carcinoma, Bronchogenic / pathology. Dura Mater / pathology. Hematoma / diagnosis. Meningeal Neoplasms / secondary. Neoplasm Metastasis / pathology
  • [MeSH-minor] Aged. Diagnosis, Differential. Humans. Male. Paresis / diagnosis. Tomography, X-Ray Computed

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16304875.001).
  • [ISSN] 0030-9982
  • [Journal-full-title] JPMA. The Journal of the Pakistan Medical Association
  • [ISO-abbreviation] J Pak Med Assoc
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] Pakistan
  •  go-up   go-down


57. Toffart AC, Pluquet E, Timsit JF, Diab S, Moro-Sibilot D: [Bronchial carcinoma and intensive care]. Rev Pneumol Clin; 2008 Oct;64(5):250-6
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Bronchial carcinoma and intensive care].
  • [Transliterated title] Cancer bronchopulmonaire et réanimation.
  • INTRODUCTION: Lung cancer is a disease with a poor prognosis.
  • Therapeutic innovations in oncology and the optimisation of intensive care patient management have improved the prognosis of lung cancer presenting with acute life-threatening respiratory or cardiac emergencies.
  • OBSERVATION: We reported on the case of a patient with lung cancer presenting with mildly abundant haemoptysis, who was hospitalised in intensive care.
  • DISCUSSION: After years of pessimism, the medical literature has revealed an improvement in lung cancer patients' survival.
  • The mortality risk factors depend more on acute conditions than on the underlying lung cancer.
  • CONCLUSION: Consideration of the acute event is important when deciding whether to hospitalise a patient with lung cancer in intensive care.
  • [MeSH-major] Carcinoma, Squamous Cell / therapy. Critical Care. Lung Neoplasms / mortality. Lung Neoplasms / therapy
  • [MeSH-minor] APACHE. Age Factors. Aged. Data Interpretation, Statistical. Humans. Karnofsky Performance Status. Lung / pathology. Male. Neoplasm Staging. Prognosis. Prospective Studies. Radiography, Thoracic. Risk Factors. Survival Analysis. Time Factors. Tomography, X-Ray Computed. Treatment Outcome

  • MedlinePlus Health Information. consumer health - Critical Care.
  • MedlinePlus Health Information. consumer health - Lung Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18995155.001).
  • [ISSN] 0761-8417
  • [Journal-full-title] Revue de pneumologie clinique
  • [ISO-abbreviation] Rev Pneumol Clin
  • [Language] fre
  • [Publication-type] Case Reports; Comparative Study; English Abstract; Journal Article; Review
  • [Publication-country] France
  • [Number-of-references] 14
  •  go-up   go-down


58. Ridene I, Radhouani I, Ayadi A, Zidi A, Hantous-Zannad S, Baccouche I, Elmezni F, Miled-M'rad KB: [Imaging features of primary pulmonary lymphomas]. Rev Mal Respir; 2010 Nov;27(9):1069-76
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Imaging features of primary pulmonary lymphomas].
  • [Transliterated title] Imagerie des lymphomes pulmonaires primitifs.
  • All diagnoses were proven histologically by bronchial or surgical biopsies.
  • In the two cases of diffuse large B-cell lymphoma, CT showed one or more masses spreading locally, mimicking primary bronchial carcinoma.
  • In lymphomatoid granulomatosis the CT showed diffuse interstitial disease with fibrosis.
  • The diagnosis of MALT lymphoma is often difficult because its radiological appearance is often falsely reassuring.
  • [MeSH-major] Lung Neoplasms / radiography. Lymphoma / radiography

  • MedlinePlus Health Information. consumer health - Lung Cancer.
  • MedlinePlus Health Information. consumer health - Lymphoma.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] Copyright © 2010 SPLF. Published by Elsevier Masson SAS. All rights reserved.
  • (PMID = 21111278.001).
  • [ISSN] 1776-2588
  • [Journal-full-title] Revue des maladies respiratoires
  • [ISO-abbreviation] Rev Mal Respir
  • [Language] fre
  • [Publication-type] English Abstract; Journal Article
  • [Publication-country] France
  •  go-up   go-down


59. Böttger C, Warth A, Nawroth PP, Isermann B: [Neuroendocrine carcinoma of the lung: a diagnostic and therapeutic challenge]. Med Klin (Munich); 2010 Apr;105(4):237-41
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Neuroendocrine carcinoma of the lung: a diagnostic and therapeutic challenge].
  • [Transliterated title] Neuroendokrines Karzinom der Lunge: eine diagnostische und therapeutische Herausforderung.
  • Based on a biopsy of a bronchial tumor, a small cell neuroendocrine tumor of the lung was diagnosed and chemotherapy with etoposide and cisplatin was initiated.
  • As the tumor progressed under chemotherapy, the bronchial biopsy was reevaluated and further biopsies of liver and adrenal metastases were obtained.
  • The diagnosis was corrected, and an atypical neuroendocrine bronchial carcinoma was diagnosed.
  • Under octreotide therapy, the patient remained stable for 1 year, when a discrete progress of the primary tumor in the lung was observed.
  • Based on this case, the diagnostic criteria, prognostic factors and therapeutic options of neuroendocrine bronchial carcinomas are discussed.
  • [MeSH-major] Adrenal Gland Neoplasms / secondary. Carcinoma, Bronchogenic / diagnosis. Carcinoma, Bronchogenic / pathology. Carcinoma, Bronchogenic / secondary. Carcinoma, Medullary / diagnosis. Carcinoma, Medullary / pathology. Carcinoma, Neuroendocrine / diagnosis. Carcinoma, Neuroendocrine / secondary. Liver Neoplasms / diagnosis. Liver Neoplasms / secondary. Lung Neoplasms / diagnosis. Lung Neoplasms / pathology. Neoplasms, Multiple Primary / diagnosis. Neoplasms, Multiple Primary / pathology. Thyroid Neoplasms / diagnosis. Thyroid Neoplasms / pathology
  • [MeSH-minor] Adrenal Glands / pathology. Antineoplastic Combined Chemotherapy Protocols / adverse effects. Antineoplastic Combined Chemotherapy Protocols / therapeutic use. Biomarkers, Tumor / metabolism. Bone Neoplasms / diagnosis. Bone Neoplasms / drug therapy. Bone Neoplasms / secondary. Calcitonin / metabolism. Cell Division / physiology. Female. Humans. Ki-67 Antigen / metabolism. Liver / pathology. Lung / pathology. Middle Aged. Neoplasm Staging. Octreotide / administration & dosage. Paraneoplastic Syndromes / diagnosis. Paraneoplastic Syndromes / drug therapy. Paraneoplastic Syndromes / pathology. Sirolimus / administration & dosage. Thyroid Gland / pathology


60. Hoffmann H, Dienemann H: [Development of thoracic surgery over the next 20 years]. Chirurg; 2009 Dec;80(12):1121-5
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Transliterated title] Entwicklung der Thoraxchirurgie in den nächsten 20 Jahren.
  • Bronchial carcinoma is the most common diagnosis in thoracic surgery patients and will remain a relevant topic for health politics for many years.
  • [MeSH-minor] Carcinoma, Bronchogenic / mortality. Carcinoma, Bronchogenic / surgery. Cause of Death. Forecasting. Germany. Health Services Needs and Demand / trends. Humans. Lung Diseases / mortality. Lung Diseases / surgery. Lung Neoplasms / mortality. Lung Neoplasms / surgery. Minimally Invasive Surgical Procedures / trends. Patient Care Team / trends

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Ann Thorac Surg. 2005 Dec;80(6):2051-6; discussion 2056 [16305843.001]
  • [Cites] N Engl J Med. 2001 Jul 19;345(3):181-8 [11463014.001]
  • [Cites] Ann Thorac Surg. 2006 Aug;82(2):431-43 [16888872.001]
  • [Cites] Ann Thorac Surg. 2009 Feb;87(2):379-84 [19161742.001]
  • [Cites] JAMA. 1998 Nov 25;280(20):1747-51 [9842949.001]
  • [Cites] Ann Surg. 2007 May;245(5):777-83 [17457171.001]
  • [Cites] Eur Respir J. 2010 Mar;35(3):479-95 [19717482.001]
  • [Cites] Ann Thorac Surg. 2005 Jun;79(6):S2232-7 [15919258.001]
  • [Cites] Thorax. 2007 Nov;62(11):991-7 [17573442.001]
  • [Cites] N Engl J Med. 2003 May 22;348(21):2059-73 [12759479.001]
  • [Cites] Lancet. 1997 May 17;349(9063):1436-42 [9164317.001]
  • [Cites] N Engl J Med. 2003 Nov 27;349(22):2117-27 [14645640.001]
  • [Cites] Chirurg. 2007 Nov;78(11):1012-7 [17932631.001]
  • [Cites] Chest. 1998 Sep;114(3):675-80 [9743149.001]
  • [Cites] Chirurg. 2005 Feb;76(2):126-30 [15551005.001]
  • (PMID = 19924358.001).
  • [ISSN] 1433-0385
  • [Journal-full-title] Der Chirurg; Zeitschrift fur alle Gebiete der operativen Medizen
  • [ISO-abbreviation] Chirurg
  • [Language] ger
  • [Publication-type] English Abstract; Journal Article
  • [Publication-country] Germany
  •  go-up   go-down


61. Gernez Y, Barlesi F, Astoul P, Magnan A: [Hypersensitivity to carboplatin. An effect of generic drugs?]. Rev Mal Respir; 2006 Jun;23(3 Pt 1):269-72
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • CASE REPORTS: We report the cases of 2 patients, treated for undifferentiated bronchial carcinoma and carcinoma of the breast, presenting with hypersensitivity reactions to carboplatin developing after 6 and 8 courses respectively.

  • MedlinePlus Health Information. consumer health - Drug Reactions.
  • COS Scholar Universe. author profiles.
  • Hazardous Substances Data Bank. CARBOPLATIN .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [CommentIn] Rev Mal Respir. 2006 Nov;23(5 Pt 1):487-8 [17314753.001]
  • (PMID = 16788528.001).
  • [ISSN] 0761-8425
  • [Journal-full-title] Revue des maladies respiratoires
  • [ISO-abbreviation] Rev Mal Respir
  • [Language] fre
  • [Publication-type] Case Reports; English Abstract; Journal Article
  • [Publication-country] France
  • [Chemical-registry-number] 0 / Antineoplastic Agents; 0 / Drugs, Generic; BG3F62OND5 / Carboplatin
  •  go-up   go-down


62. Sun J, Han B, Zhang J, Zhao H, Qi D, Shen J, Gu A: [Role of endobronchial ultrasound-guided transbronchial needle aspiration in the diagnosis of bronchogenic carcinoma]. Zhongguo Fei Ai Za Zhi; 2010 May;13(5):432-7
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Role of endobronchial ultrasound-guided transbronchial needle aspiration in the diagnosis of bronchogenic carcinoma].
  • BACKGROUND AND OBJECTIVE: The aim of this study is to evaluate diagnostic yield and the safety of endobronchial ultrasound-guided transbronchial needle aspiration (EBUS-TBNA) in the diagnosis ofbronchogenic carcinoma.
  • RESULTS: In all 95 patients, 60 cases were newly diagnosed lung cancer through the pathological examination and clinical follow-up certification.
  • In 60 lung cancer cases, 112 samples were obtained from lymph nodes (LNs) and 11 samples were obtained from intrapulmonary lesions.
  • Sensitivity and specificity of EBUS-guided TBNA method in distinguishing benign from malignant LNs or thoracic masses were 96.67% and 100%, respectively.
  • CONCLUSION: EBUSTBNA seemed a safe and effective technique in making bronchogenic carcinoma diagnosis for mediastinal/hilar LNs and intra-pulmonary masses.
  • [MeSH-major] Biopsy, Fine-Needle / methods. Bronchi / pathology. Bronchi / ultrasonography. Carcinoma, Bronchogenic / diagnosis. Endosonography / methods. Lung Neoplasms / diagnosis

  • MedlinePlus Health Information. consumer health - Lung Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 20677637.001).
  • [ISSN] 1009-3419
  • [Journal-full-title] Zhongguo fei ai za zhi = Chinese journal of lung cancer
  • [ISO-abbreviation] Zhongguo Fei Ai Za Zhi
  • [Language] chi
  • [Publication-type] English Abstract; Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] China
  •  go-up   go-down


63. Moghissi K, Dixon K: Photodynamic therapy for synchronous occult bronchial cancer 17 years after pneumonectomy. Interact Cardiovasc Thorac Surg; 2005 Aug;4(4):327-8
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Photodynamic therapy for synchronous occult bronchial cancer 17 years after pneumonectomy.
  • We present a patient with radiologically occult double synchronous bronchial neoplastic lesions 17 years after right pneumonectomy.
  • Chest radiograph and CT scan of the thorax showed no abnormalities of the residual lung fields nor mediastinal lymphadenopathy.
  • Standard white light bronchoscopy (WLB) revealed a tumour in the left lower lobe bronchus.
  • AFB played a crucial role in diagnosis and ensuring completeness of treatment by PDT in this case with encouraging early results illustrating the respective value of AFB and PDT in such cases.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17670423.001).
  • [ISSN] 1569-9285
  • [Journal-full-title] Interactive cardiovascular and thoracic surgery
  • [ISO-abbreviation] Interact Cardiovasc Thorac Surg
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] England
  •  go-up   go-down


64. Lin YT, Chen TL, Siu LK, Hsu SF, Fung CP: Clinical and microbiological characteristics of community-acquired thoracic empyema or complicated parapneumonic effusion caused by Klebsiella pneumoniae in Taiwan. Eur J Clin Microbiol Infect Dis; 2010 Aug;29(8):1003-10
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Diabetes mellitus, liver cirrhosis, and bronchogenic carcinoma were independent risk factors for K. pneumoniae infection.

  • Genetic Alliance. consumer health - Klebsiella.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Emerg Infect Dis. 2007 Jul;13(7):986-93 [18214169.001]
  • [Cites] J Am Geriatr Soc. 2005 Jul;53(7):1203-9 [16108939.001]
  • [Cites] Clin Infect Dis. 1998 Jun;26(6):1434-8 [9636876.001]
  • [Cites] Chest. 1995 Aug;108(2):299-301 [7634854.001]
  • [Cites] J Clin Microbiol. 2007 Feb;45(2):466-71 [17151209.001]
  • [Cites] Intern Med. 2007;46(15):1173-8 [17675765.001]
  • [Cites] J Hyg (Lond). 1978 Oct;81(2):219-25 [701786.001]
  • [Cites] Chest. 2007 Aug;132(2):532-9 [17699132.001]
  • [Cites] Respiration. 2008;75(3):241-50 [18367849.001]
  • [Cites] Infection. 2008 Aug;36(4):328-34 [18642112.001]
  • [Cites] Emerg Infect Dis. 2002 Feb;8(2):160-6 [11897067.001]
  • [Cites] Clin Infect Dis. 2006 May 15;42(10):1351-8 [16619144.001]
  • [Cites] N Engl J Med. 2005 Mar 3;352(9):865-74 [15745977.001]
  • [Cites] Gut. 2002 Mar;50(3):420-4 [11839725.001]
  • [Cites] FEMS Microbiol Lett. 2008 Jul;284(2):247-52 [18507682.001]
  • [Cites] Arch Intern Med. 1991 Aug;151(8):1557-9 [1872659.001]
  • [Cites] Clin Infect Dis. 2007 Dec 1;45(11):1530-1; author reply 1532-3 [17990243.001]
  • [Cites] J Infect Dis. 2006 Aug 1;194(3):403-4; author reply 404-5 [16826492.001]
  • [Cites] South Med J. 2008 May;101(5):484-9 [18414163.001]
  • [Cites] Eur J Clin Microbiol Infect Dis. 2010 Jun;29(6):689-98 [20383552.001]
  • [Cites] Chest. 2000 Jun;117(6):1685-9 [10858403.001]
  • [Cites] Curr Opin Pulm Med. 2004 Jul;10(4):299-304 [15220756.001]
  • [Cites] J Infect Dis. 2000 Jun;181(6):2075-9 [10837197.001]
  • (PMID = 20505967.001).
  • [ISSN] 1435-4373
  • [Journal-full-title] European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology
  • [ISO-abbreviation] Eur. J. Clin. Microbiol. Infect. Dis.
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] Germany
  •  go-up   go-down


65. Mach N: [Screening for lung cancer in 2006: is there a validated test?]. Rev Med Suisse; 2006 May 17;2(66):1333-4, 1336-7
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Screening for lung cancer in 2006: is there a validated test?].
  • [Transliterated title] Peut-on proposer un test de dépistage du cancer du poumon en 2006?
  • Lung cancer is by far the most common cause of death from any tumor.
  • This is partly due to the late stage of most bronchial carcinoma at the time of diagnosis.
  • Curative treatment by surgery is possible only for localized disease.
  • Improvement in medical imaging lead to a new hope that low-dose CT scan may be an efficient screening tool for lung cancer.
  • So far no screening technique has been able to demonstrate an impact on lung cancer mortality despite the higher sensitivity to detect smaller lung tumors.
  • Therefore, in 2006, screening for lung cancer can not be recommended.
  • [MeSH-major] Lung Neoplasms / diagnosis. Mass Screening / methods

  • Genetic Alliance. consumer health - Lung Cancer.
  • MedlinePlus Health Information. consumer health - Lung Cancer.
  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16775994.001).
  • [ISSN] 1660-9379
  • [Journal-full-title] Revue médicale suisse
  • [ISO-abbreviation] Rev Med Suisse
  • [Language] fre
  • [Publication-type] English Abstract; Journal Article; Review
  • [Publication-country] Switzerland
  • [Number-of-references] 18
  •  go-up   go-down


66. Paramez AR, Dixit R, Gupta N, Gupta R, Arya M: Non-small cell lung carcinoma presenting as carcinomatous meningitis. Lung India; 2010 Jul;27(3):158-60
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Non-small cell lung carcinoma presenting as carcinomatous meningitis.
  • Meningeal carcinomatosis is a diffuse infiltration of leptomeninges and sub arachnoid space by malignant cells metastasizing from systemic cancer.
  • Primary bronchogenic carcinoma presenting as carcinomatous meningitis is a very rare occurrence in clinical practice, often occurring during the treatment course of the underlying malignancy.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 20931036.001).
  • [ISSN] 0974-598X
  • [Journal-full-title] Lung India : official organ of Indian Chest Society
  • [ISO-abbreviation] Lung India
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] India
  • [Other-IDs] NLM/ PMC2946719
  • [Keywords] NOTNLM ; Adenocarcinoma lung / carcinomatous meningitis / malignant metastasis
  •  go-up   go-down


67. Kim AW, Liptay MJ, Saclarides TJ, Warren WH: Endobronchial colorectal metastasis versus primary lung cancer: a tale of two sleeve right upper lobectomies. Interact Cardiovasc Thorac Surg; 2009 Aug;9(2):379-81
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Endobronchial colorectal metastasis versus primary lung cancer: a tale of two sleeve right upper lobectomies.
  • Endobronchial metastasis from colorectal carcinoma is relatively uncommon whereas primary bronchogenic carcinoma is more common.
  • These two disease entities can both appear to be similar clinically and radiographically.
  • Palliative treatment rather than a curative-intent anatomic resection is typically employed in the setting of endobronchial metastatic disease.
  • We compare two cases of patients with a history of colorectal carcinoma with endobronchial lesions of which one was truly a metastatic lesion.
  • [MeSH-major] Adenocarcinoma / surgery. Carcinoma, Non-Small-Cell Lung / surgery. Colorectal Neoplasms / pathology. Lung Neoplasms / surgery. Pneumonectomy
  • [MeSH-minor] Diagnosis, Differential. Humans. Lymph Node Excision. Male. Middle Aged. Neoplasm Staging. Tomography, X-Ray Computed. Treatment Outcome


68. Surov A, Hainz M, Holzhausen HJ, Arnold D, Katzer M, Schmidt J, Spielmann RP, Behrmann C: Skeletal muscle metastases: primary tumours, prevalence, and radiological features. Eur Radiol; 2010 Mar;20(3):649-58
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Skeletal muscle metastases: primary tumours, prevalence, and radiological features.
  • The reported prevalence of skeletal muscle metastases from post-mortem studies of patients with cancer is inconstant and ranges from 0.03 to 17.5%.
  • MATERIALS AND METHODS: Of 5,170 patients with metastasised cancer examined and treated at our institution during the period from January 2000 to December 2007, 61 patients with muscle metastases (80 lesions) were identified on computed tomography (CT).
  • Genital tumours (24.6%) were the most frequent malignancies metastasising into the skeletal musculature, followed by gastrointestinal tumours (21.3%), urological tumours (16.4%), and malignant melanoma (13.1%).
  • Other primary malignancies were rarer, including bronchial carcinoma (8.2%), thyroid gland carcinoma (4.9%), and breast carcinoma (3.3%).
  • In 8.2%, carcinoma of unknown primary was diagnosed.

  • MedlinePlus Health Information. consumer health - CT Scans.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Rev Esp Oncol. 1984;31(1):57-67 [6545428.001]
  • [Cites] AJR Am J Roentgenol. 2001 May;176(5):1165-6 [11312174.001]
  • [Cites] Clin Radiol. 1999 Feb;54(2):85-9 [10050734.001]
  • [Cites] BMC Med Imaging. 2007 Dec 12;7:8 [18076764.001]
  • [Cites] Eur Radiol. 2004 Nov;14 (11):1974-9 [15480695.001]
  • [Cites] Clin Radiol. 1995 Oct;50(10 ):730-1 [7586971.001]
  • [Cites] Adv Exp Med Biol. 1992;324:83-92 [1492628.001]
  • [Cites] Skeletal Radiol. 1996 Jul;25(5):425-30 [8837273.001]
  • [Cites] Radiology. 1997 Apr;203(1):237-44 [9122401.001]
  • [Cites] Eur Radiol. 1998;8(7):1140-1 [9724426.001]
  • [Cites] AJR Am J Roentgenol. 2002 Apr;178(4):985-8 [11906887.001]
  • [Cites] Ann Surg. 1940 Jul;112(1):138-49 [17857618.001]
  • [Cites] Singapore Med J. 2003 Jun;44(6):302-3 [14560863.001]
  • [Cites] Surg Today. 2000;30(12):1118-23 [11193747.001]
  • [Cites] Eur Radiol. 2001;11(11):2314-6 [11702178.001]
  • [Cites] Ups J Med Sci. 2005;110(1):75-83 [15801688.001]
  • [Cites] Cancer. 1977 Jul;40(1):67-71 [880573.001]
  • [Cites] Eur Radiol. 2007 May;17 (5):1172-80 [17021702.001]
  • [Cites] Clin Exp Metastasis. 1996 May;14(3):189-96 [8674272.001]
  • [Cites] Br J Urol. 1990 Oct;66(4):411-4 [2224435.001]
  • [Cites] J Laryngol Otol. 2001 Jan;115(1):65-7 [11233631.001]
  • [Cites] Eur Radiol. 2000;10 (3):521-6 [10757009.001]
  • [Cites] Eur Radiol. 2008 Feb;18(2):417-21 [18246358.001]
  • [Cites] Skeletal Radiol. 2007 Dec;36(12):1109-19 [17554538.001]
  • [Cites] Spine (Phila Pa 1976). 1996 Oct 1;21(19):2243-50 [8902969.001]
  • [Cites] Clin Radiol. 1997 Mar;52(3):203-12 [9091255.001]
  • [Cites] Cancer. 1987 Apr 15;59(8):1530-4 [2434211.001]
  • [Cites] Orthopedics. 2002 Nov;25(11):1297-9 [12452352.001]
  • [Cites] Eur Radiol. 1998;8(6):939-45 [9683697.001]
  • [Cites] Am J Phys Med Rehabil. 1998 Nov-Dec;77(6):553-6 [9862545.001]
  • [Cites] Am J Surg Pathol. 1987 May;11(5):359-66 [3578646.001]
  • [Cites] Ann Rheum Dis. 1984 Feb;43(1):95-7 [6607713.001]
  • [Cites] Clin Radiol. 2003 Nov;58(11):883-5 [14581013.001]
  • [Cites] Muscle Nerve. 1996 Oct;19(10):1291-301 [8808655.001]
  • [Cites] Eur Radiol. 2008 Nov;18(11):2628-34 [18493781.001]
  • [Cites] Eur Radiol. 2000;10(5):841-3 [10823644.001]
  • [Cites] Eur Radiol. 1999;9(6):1104-6 [10415243.001]
  • [Cites] Ann Surg Oncol. 2000 Aug;7(7):526-34 [10947022.001]
  • [Cites] Neurology. 1959 Nov;9:757-66 [14431247.001]
  • [Cites] Br J Urol. 1996 Jan;77(1):155-6 [8653293.001]
  • [Cites] J Orthop Sci. 2001;6(2):189-92 [11484108.001]
  • [Cites] AJR Am J Roentgenol. 2000 Feb;174(2):401-4 [10658714.001]
  • [Cites] Radiographics. 2000 Oct;20 Spec No:S53-66 [11046162.001]
  • [Cites] Rev Rhum Engl Ed. 1997 Jun;64(6):433 [9513621.001]
  • [Cites] Am J Clin Oncol. 1993 Jun;16(3):229-31 [8338057.001]
  • [Cites] Clin Orthop Relat Res. 1998 Oct;(355):272-81 [9917613.001]
  • [Cites] Abdom Imaging. 2004 Sep-Oct;29(5):619-22 [15162230.001]
  • [Cites] Med Hypotheses. 1980 Feb;6(2):133-7 [7393016.001]
  • [Cites] Eur Radiol. 1999;9(2):208-10 [10101640.001]
  • [Cites] Eur Radiol. 1998;8(8):1366-9 [9853216.001]
  • [Cites] Am J Dermatopathol. 2009 Jun;31(4):367-9 [19461241.001]
  • [Cites] Neoplasia. 2001 Mar-Apr;3(2):125-31 [11420748.001]
  • [Cites] Skeletal Radiol. 2000 May;29(5):270-4 [10883446.001]
  • [Cites] Skeletal Radiol. 2005 Oct;34(10 ):609-19 [16132978.001]
  • [Cites] Clin Exp Metastasis. 1989 Sep-Oct;7(5):483-91 [2752602.001]
  • [Cites] Eur Radiol. 1999;9(4):662-4 [10354880.001]
  • [Cites] Radiology. 1986 Sep;160(3):683-7 [3737906.001]
  • [Cites] Jpn J Clin Oncol. 2004 Apr;34(4):210-4 [15121758.001]
  • [Cites] Clin Radiol. 2007 Jan;62(1):18-27 [17145259.001]
  • (PMID = 19707767.001).
  • [ISSN] 1432-1084
  • [Journal-full-title] European radiology
  • [ISO-abbreviation] Eur Radiol
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] Germany
  •  go-up   go-down


69. Briese V, Szabo DG, Than GN, Willroth PO, Brieses J: Tumor markers (pregnancy protein 1, placental-specific tissue protein 10, placental-specific tissue protein 12, alpha1-fetoprotein) in patients with bronchial carcinoma. Anticancer Res; 2005 May-Jun;25(3A):1667-70
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Tumor markers (pregnancy protein 1, placental-specific tissue protein 10, placental-specific tissue protein 12, alpha1-fetoprotein) in patients with bronchial carcinoma.
  • The concentrations of pregnancy protein 1 (SP1), placental-specific tissue protein 10 (PP10), placental-specific tissue protein 12 (PP12) and alpha1-Fetoprotein (AFP) were analyzed in serum samples of 83 patients with bronchial carcinoma at stages II-IV Protein levels were determined by means of single radial immunodiffusion, rocket immuno-electrophoresis, radioimmunoassay and enzyme- immunoassay.
  • PP12 and AFP serum concentrations were significantly increased in the cancer group compared with the control group.
  • [MeSH-major] Biomarkers, Tumor / blood. Bronchial Neoplasms / blood

  • Genetic Alliance. consumer health - Pregnancy.
  • NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16033079.001).
  • [ISSN] 0250-7005
  • [Journal-full-title] Anticancer research
  • [ISO-abbreviation] Anticancer Res.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] Greece
  • [Chemical-registry-number] 0 / Biomarkers, Tumor; 0 / Glycoproteins; 0 / IGFBP1 protein, human; 0 / Insulin-Like Growth Factor Binding Protein 1; 0 / Insulin-Like Growth Factor Binding Proteins; 0 / Pregnancy Proteins; 0 / alpha-Fetoproteins
  •  go-up   go-down


70. Gosney M: Under-investigation of older people with abnormal chest radiographs. Gerontology; 2005 Jan-Feb;51(1):1-6
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • BACKGROUND: Whilst many authors have previously suggested that older people are under-represented in the investigation and management of lung cancer, few data are available as to the effect of age on the subsequent investigation and management of a patient with an abnormal chest radiograph.
  • METHODS: During a 3-month period in a university teaching hospital, all abnormal chest radiographs suggestive of a possible diagnosis of lung cancer were identified, and patients subsequently followed to determine investigation, management and date of death over a 5-year period.
  • Of the 80 patients with a possible bronchial carcinoma only 59% had a further chest radiograph performed.
  • In more of the older group a presumed death certificate diagnosis of pneumonia was made.
  • When an abnormal chest radiograph raises the possibility of an underlying bronchial carcinoma, the finding of this study suggests that an ageist attitude influences the subsequent management of some patients.
  • [MeSH-major] Lung / radiography. Lung Neoplasms / diagnosis

  • MedlinePlus Health Information. consumer health - Lung Cancer.
  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] Copyright (c) 2005 S. Karger AG, Basel
  • (PMID = 15591749.001).
  • [ISSN] 0304-324X
  • [Journal-full-title] Gerontology
  • [ISO-abbreviation] Gerontology
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] Switzerland
  •  go-up   go-down


71. Vereş L, Mihdescu T, Beda E: [Pulmonary thromboembolism: specifics of diagnosis in young age--case report]. Pneumologia; 2009 Jan-Mar;58(1):49-51
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Pulmonary thromboembolism: specifics of diagnosis in young age--case report].
  • [Transliterated title] Trombembolismul pulmonar: particularităţi de diagnostic la adultul tânăr--caz clinic.
  • It is considered that PTE causes pleural effusions more frequently than bronchogenic carcinoma although statistics bring it to less than 5% of diagnosed cases.
  • This probably relies in an insufficient investigation of patients with pleural effusion as well as considering PTE a rare cause of disease.
  • Our case reveals both a delay in the diagnosis as well as a genetic linkage for PTE.
  • [MeSH-major] Pulmonary Embolism / diagnosis
  • [MeSH-minor] Anti-Bacterial Agents / therapeutic use. Anticoagulants / therapeutic use. Diagnosis, Differential. Humans. Male. Pleural Effusion / diagnosis. Pleural Effusion / etiology. Pneumonia / complications. Risk Factors. Smoking / adverse effects. Treatment Outcome. Young Adult

  • MedlinePlus Health Information. consumer health - Pulmonary Embolism.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19507487.001).
  • [ISSN] 2067-2993
  • [Journal-full-title] Pneumologia (Bucharest, Romania)
  • [ISO-abbreviation] Pneumologia
  • [Language] rum
  • [Publication-type] Case Reports; English Abstract; Journal Article
  • [Publication-country] Romania
  • [Chemical-registry-number] 0 / Anti-Bacterial Agents; 0 / Anticoagulants
  •  go-up   go-down


72. Shrestha HG, Chokhani R, Dhakhwa R: Clinicopathologic profile of bronchogenic carcinoma. JNMA J Nepal Med Assoc; 2010 Apr-Jun;49(178):100-3
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Clinicopathologic profile of bronchogenic carcinoma.
  • INTRODUCTION: Bronchogenic carcinoma is the most common cancer in the world.
  • Accurate diagnosis and categorization into different types is important because of its effect on prognosis and management.
  • We conducted this study to find out the frequency of various histological types of bronchogenic carcinoma and correlate with their clinicopathologic profile.
  • METHODS: This is a retrospective study conducted in 174 histopathologically proven cases of bronchogenic carcinoma that were referred from different parts of the country to a private hospital in Kathmandu over a period of 4 years.
  • RESULTS: The mean age of the patients developing bronchogenic carcinoma was 64 years.
  • Squamous cell carcinoma was the commonest histologic subtype followed by small cell carcinoma.
  • CONCLUSIONS: The lung cancer must be ruled out in all patients who have persistent signs and symptoms of pulmonary disease with a history of smoking.
  • [MeSH-major] Carcinoma / pathology. Lung Neoplasms / pathology

  • MedlinePlus Health Information. consumer health - Lung Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 21485592.001).
  • [ISSN] 0028-2715
  • [Journal-full-title] JNMA; journal of the Nepal Medical Association
  • [ISO-abbreviation] JNMA J Nepal Med Assoc
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] Nepal
  •  go-up   go-down


73. Disdier C, Bollo E, Morales P, Montero C: [Annual review of Archivos de Neumología in interventional pneumology, interstitial diseases and lung transplantation]. Arch Bronconeumol; 2009;45 Suppl 1:39-42
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Annual review of Archivos de Neumología in interventional pneumology, interstitial diseases and lung transplantation].
  • [Transliterated title] Revista del año de Archivos de Neumología en neumología intervencionista, enfermedades intersticiales y trasplante pulmonar.
  • A review has been made of original articles on invasive pneumology techniques, interstitial diseases and lung transplantation, published in the Archivos de Bronconeumología during the year 2008.
  • We have selected the publication by Martínez-Olondrins et al on the mediastinal staging of bronchogenic carcinoma by <<blind>> transbronchial needle aspiration to highlight the role of this simple, safe and cost-effective technique at a time when aspiration by ultrasound-guided bronchoscopy is profiled as an alternative to staging by mediastinoscopy.
  • Besides its usefulness in the study of lymph nodes, transbronchial needle aspiration increases the overall performance of bronchoscopy by 20%, which means that it should be considered as a basic tool in the study of lung cancer.
  • We also comment on the work by Galvis-Caravajal et al, who describe percutaneous radiofrequency as an alternative to radiotherapy in small lung or metastasic tumours.
  • In diffuse interstitial disease, Morell et al analysed the diagnostic methods in 500 patients with this clinical-radiological presentation in which a definitive diagnosis was achieved in 85%, with 25% of them being obtained by non-invasively.
  • Baloira et al analysed the characteristics of 19 patients with desquamative interstitial pneumonia and respiratory bronchiolitis associated-interstitial lung disease obtained from the National register of Interstitial Diseases.
  • [MeSH-major] Lung Diseases / surgery. Lung Transplantation. Periodicals as Topic. Publishing
  • [MeSH-minor] Algorithms. Humans. Lung Diseases, Interstitial / surgery

  • Genetic Alliance. consumer health - Transplantation.
  • MedlinePlus Health Information. consumer health - Lung Diseases.
  • MedlinePlus Health Information. consumer health - Lung Transplantation.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19303530.001).
  • [ISSN] 0300-2896
  • [Journal-full-title] Archivos de bronconeumología
  • [ISO-abbreviation] Arch. Bronconeumol.
  • [Language] spa
  • [Publication-type] English Abstract; Journal Article; Review
  • [Publication-country] Spain
  • [Number-of-references] 27
  •  go-up   go-down


74. Prisadov GC, Landes T, Kruger G: Thoracoscopic resection of solitary pulmonary nodules in patients with previous malignant tumors. Folia Med (Plovdiv); 2010 Oct-Dec;52(4):23-6
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Thoracoscopic resection of solitary pulmonary nodules in patients with previous malignant tumors.
  • These presumed metastases are, however, very often diagnosed later as benign lesions or primary malignant pulmonary tumors.
  • METHOD: The study included 22 patients with solitary pulmonary nodules and history of previous malignant tumors who underwent video-assisted thoracoscopic surgery at the Clinic of Vascular and Thoracic Surgery, University Hospital Aschersleben, Germany between 01.01.2006 and 31.12.2009.
  • RESULTS: A diagnosis of pulmonary metastasis was confirmed in only 8 of the patients (36.4%).
  • In another 8 of them (36.4%) the solitary pulmonary nodule proved to be a primary lung cancer, i.e. a second malignant tumor.
  • The bronchial carcinoma was synchronous with the primary tumor in four of these patients, and metachronous in the rest.
  • CONCLUSIONS: Not all solitary pulmonary nodules in patients with preceding malignant formations are metastases.
  • [MeSH-major] Lung Neoplasms / secondary. Neoplasms / pathology. Solitary Pulmonary Nodule / secondary. Thoracic Surgery, Video-Assisted
  • [MeSH-minor] Biopsy. Humans. Neoplasms, Multiple Primary / pathology. Neoplasms, Multiple Primary / surgery. Treatment Outcome

  • MedlinePlus Health Information. consumer health - Lung Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 21462888.001).
  • [ISSN] 0204-8043
  • [Journal-full-title] Folia medica
  • [ISO-abbreviation] Folia Med (Plovdiv)
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] Bulgaria
  •  go-up   go-down


75. Streffer C: Strong association between cancer and genomic instability. Radiat Environ Biophys; 2010 May;49(2):125-31
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Strong association between cancer and genomic instability.
  • In the development of cancer, several mutations are involved.
  • Several studies show that genomic instability is increased not only in the cancer cells but also in "normal" cells of cancer patients e.g. peripheral lymphocytes.
  • This has for example been shown in uranium miners with bronchial carcinomas, but also in untreated head and neck cancer patients.
  • The association between cancer and genomic instability is also found in individuals with a genetic predisposition for increased radiosensitivity.
  • In all cases, an increased genomic instability, cancer proneness and increased radiosensitivity coincide.
  • Genomic instability apparently promotes cancer development.
  • In this context, it is interesting that hypoxia, increased genomic instability and cancer are also associated.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Cancer Cell. 2008 Oct 7;14(4):312-23 [18835033.001]
  • [Cites] Int J Radiat Oncol Biol Phys. 2007 Jun 1;68(2):465-71 [17418962.001]
  • [Cites] Nat Rev Cancer. 2009 Aug;9(8):596-604 [19629073.001]
  • [Cites] Mutat Res. 2004 Dec 2;568(1):79-87 [15530541.001]
  • [Cites] Int J Radiat Biol. 1988 Sep;54(3):381-94 [2900860.001]
  • [Cites] Int J Radiat Biol. 1989 Jan;55(1):85-92 [2562980.001]
  • [Cites] Cancer Genet Cytogenet. 2006 Mar;165(2):98-105 [16527603.001]
  • [Cites] Mutat Res. 1999 Aug 11;429(1):85-92 [10434025.001]
  • [Cites] Int J Radiat Biol. 2001 Nov;77(11):1087-93 [11683979.001]
  • [Cites] Int J Radiat Oncol Biol Phys. 2009 Aug 1;74(5):1323-31 [19616740.001]
  • [Cites] J Mol Med (Berl). 2007 Feb;85(2):139-48 [17180667.001]
  • [Cites] Mutat Res. 2009 Jul 31;668(1-2):92-102 [19622405.001]
  • [Cites] Nature. 1992 Feb 20;355(6362):738-40 [1741061.001]
  • [Cites] Cancer Res. 2007 Feb 15;67(4):1415-8 [17308077.001]
  • [Cites] Radiat Environ Biophys. 2004 May;43(1):7-13 [15071746.001]
  • [Cites] Health Phys. 2006 Nov;91(5):416-26 [17033451.001]
  • [Cites] Nat Rev Cancer. 2009 Jul;9(7):489-99 [19536109.001]
  • [Cites] Hum Mol Genet. 2008 May 15;17(10):1363-72 [18211953.001]
  • [Cites] Cancer. 2009 Aug 15;115(16):3782-90 [19517458.001]
  • [Cites] Oncogene. 2003 Oct 13;22(45):7087-93 [14557814.001]
  • [Cites] Br J Cancer. 2007 Jun 4;96(11):1707-10 [17486133.001]
  • [Cites] Radiat Res. 2009 Aug;172(2):234-43 [19630528.001]
  • (PMID = 20033424.001).
  • [ISSN] 1432-2099
  • [Journal-full-title] Radiation and environmental biophysics
  • [ISO-abbreviation] Radiat Environ Biophys
  • [Language] eng
  • [Publication-type] Journal Article; Review
  • [Publication-country] Germany
  • [Number-of-references] 50
  •  go-up   go-down


76. Chatterjee B, Berger D, Joost Ch, Stucki A: [Atypical case of bronchus carcinoma]. Praxis (Bern 1994); 2008 Dec 3;97(24):1301-3
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Atypical case of bronchus carcinoma].
  • At time of diagnosis the stadium is often already advanced, the patient is inoperable.
  • Histological diagnosis was non small cell lung cancer (NSCLC).
  • [MeSH-major] Brain Neoplasms / secondary. Carcinoma, Non-Small-Cell Lung. Lung Neoplasms
  • [MeSH-minor] Antidiuretic Agents / therapeutic use. Antineoplastic Agents / administration & dosage. Antineoplastic Agents / therapeutic use. Antineoplastic Agents, Phytogenic / administration & dosage. Antineoplastic Agents, Phytogenic / therapeutic use. Antineoplastic Combined Chemotherapy Protocols / therapeutic use. Carboplatin / administration & dosage. Carboplatin / therapeutic use. Deamino Arginine Vasopressin / therapeutic use. Diabetes Insipidus / complications. Diabetes Insipidus / diagnosis. Diabetes Insipidus / drug therapy. Diagnosis, Differential. Humans. Lung / pathology. Male. Middle Aged. Neoplasm Metastasis. Palliative Care. Polyuria / complications. Radiography, Thoracic. Radiotherapy Dosage. Vinblastine / administration & dosage. Vinblastine / analogs & derivatives. Vinblastine / therapeutic use

  • MedlinePlus Health Information. consumer health - Brain Tumors.
  • MedlinePlus Health Information. consumer health - Lung Cancer.
  • Hazardous Substances Data Bank. CARBOPLATIN .
  • Hazardous Substances Data Bank. VINORELBINE .
  • Hazardous Substances Data Bank. VINBLASTINE .
  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19048509.001).
  • [ISSN] 1661-8157
  • [Journal-full-title] Praxis
  • [ISO-abbreviation] Praxis (Bern 1994)
  • [Language] ger
  • [Publication-type] Case Reports; English Abstract; Journal Article
  • [Publication-country] Switzerland
  • [Chemical-registry-number] 0 / Antidiuretic Agents; 0 / Antineoplastic Agents; 0 / Antineoplastic Agents, Phytogenic; 5V9KLZ54CY / Vinblastine; BG3F62OND5 / Carboplatin; ENR1LLB0FP / Deamino Arginine Vasopressin; Q6C979R91Y / vinorelbine
  •  go-up   go-down


77. Baumgart D, Egelhof T: [Preventive whole-body screening encompassing modern imaging using magnetic resonance tomography]. Herz; 2007 Aug;32(5):387-94
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Transliterated title] Präventives Ganzkörperscreening unter Einbeziehung moderner Bildgebung mit Hilfe der Magnetresonanztomographie.
  • Clinical examinations consisted of physical examination, ECG, stress ECG, lung function test, ultrasound of carotid vessels and thyroid, blood and urinary tests.
  • Most of the MR-based diagnoses were cardiovascular in nature, including 29 silent myocardial infarctions (3.2%), 27 aortic aneurysms (3%), two of them being > 5 cm in diameter, eleven intracranial extraaxial tumors (1.2%), 75 colonic polyps (8.4%), four neoplastic tumors (0.44%; three renal cell carcinomas, one bronchial carcinoma), and two cerebral aneurysms (0.22%).
  • [MeSH-major] Cardiovascular Diseases / diagnosis. Cardiovascular Diseases / prevention & control. Magnetic Resonance Imaging / trends. Mass Screening / trends. Risk Assessment / methods. Tomography / methods. Whole Body Imaging / trends


78. Toulany M, Dittmann K, Baumann M, Rodemann HP: Radiosensitization of Ras-mutated human tumor cells in vitro by the specific EGF receptor antagonist BIBX1382BS. Radiother Oncol; 2005 Feb;74(2):117-29
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • PATIENTS AND METHODS: The effect of the EGFR tyrosine kinase inhibitor BIBX1382BS on radiation sensitivity was determined after single- and fractionated-dose irradiation in human cell lines of bronchial carcinoma (A549), breast adeno-carcinoma (MDA-MB-231), pharyngeal squamous-cell carcinoma (FaDu), squamous-cell carcinoma of cervix (HTB-35) as well as normal (HSF-7) and transformed (HH4-DED) human skin fibroblasts.
  • [MeSH-minor] Adenocarcinoma / genetics. Adenocarcinoma / pathology. Breast Neoplasms / genetics. Breast Neoplasms / pathology. Carcinoma, Squamous Cell / genetics. Carcinoma, Squamous Cell / pathology. Female. Genes, ras. Genotype. Humans. Lung Neoplasms / genetics. Lung Neoplasms / pathology. Male. Pharyngeal Neoplasms / genetics. Pharyngeal Neoplasms / pathology. Phosphorylation. Radiation Tolerance. Tumor Cells, Cultured. Uterine Cervical Neoplasms / genetics. Uterine Cervical Neoplasms / pathology

  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .
  • NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 15734199.001).
  • [ISSN] 0167-8140
  • [Journal-full-title] Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology
  • [ISO-abbreviation] Radiother Oncol
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] Ireland
  • [Chemical-registry-number] 0 / BIBX 1382BS; 0 / Organic Chemicals; EC 2.7.10.1 / Receptor, Epidermal Growth Factor
  •  go-up   go-down


79. Martínez-Valles MA, Palafox-Cazarez A, Paredes-Avina JA: Severe hypokalemia, metabolic alkalosis and hypertension in a 54 year old male with ectopic ACTH syndrome: a case report. Cases J; 2009;2:6174
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Small cell lung cancer and bronchial carcinoids account for about half of the cases.
  • Malignant neoplasm has rapid and more aggressive metabolic effects.
  • We report a 54-year-old male patient with phenotypic features of Cushing's syndrome with severe hypokalemia, metabolic alkalosis, hypertension and altered mental status as manifestations of an ACTH-secreting small cell carcinoma from the lung.
  • Ectopic ACTH syndrome should be highly considered in patients with hypertension and severe hypokalemic metabolic alkalosis, especially when a lung mass is discovered.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Endocr Rev. 1994 Dec;15(6):752-87 [7705280.001]
  • [Cites] Ann Intern Med. 2003 Jun 17;138(12):980-91 [12809455.001]
  • [Cites] J Clin Endocrinol Metab. 2005 Aug;90(8):4955-62 [15914534.001]
  • [Cites] Arch Med Res. 2006 Nov;37(8):976-80 [17045113.001]
  • [Cites] Arq Bras Endocrinol Metabol. 2007 Nov;51(8):1217-25 [18209859.001]
  • [Cites] Semin Oncol. 1994 Jun;21(3 Suppl 6):23-30 [8052870.001]
  • [Cites] J Clin Endocrinol Metab. 1962 Jul;22:693-703 [14471915.001]
  • [Cites] J Clin Endocrinol Metab. 2006 Feb;91(2):371-7 [16303835.001]
  • [Cites] J Clin Oncol. 1995 Jan;13(1):157-64 [7799015.001]
  • (PMID = 19829770.001).
  • [ISSN] 1757-1626
  • [Journal-full-title] Cases journal
  • [ISO-abbreviation] Cases J
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] England
  • [Other-IDs] NLM/ PMC2740289
  •  go-up   go-down


80. Borchmann P, Behringer K, Josting A, Rueffer JU, Schnell R, Diehl V, Engert A, Kvasnicka HM, Thiele J: [Secondary malignancies after successful primary treatment of malignant Hodgkin's lymphoma]. Pathologe; 2006 Feb;27(1):47-52
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Secondary malignancies after successful primary treatment of malignant Hodgkin's lymphoma].
  • [Transliterated title] Sekundärneoplasien nach erfolgreicher Primärtherapie des malignen Hodgkin-Lymphoms.
  • Malignant Hodgkin's lymphoma (HL) has become a curable disease through the increasing intensity of the treatment strategies applied.
  • In 127 patients a secondary solid tumor was diagnosed (cumulative risk 2%, median follow-up 72 months), with bronchial carcinomas (23.6%) and colorectal adenocarcinomas (20.5%) being the most frequent neoplasms.
  • [MeSH-major] Antineoplastic Agents / therapeutic use. Hodgkin Disease / drug therapy. Neoplasms, Second Primary / chemically induced. Neoplasms, Second Primary / epidemiology
  • [MeSH-minor] Cohort Studies. Humans. Leukemia, Myeloid, Acute / chemically induced. Leukemia, Myeloid, Acute / pathology. Neoplasm Staging. Retrospective Studies

  • Genetic Alliance. consumer health - Primary malignant lymphoma.
  • MedlinePlus Health Information. consumer health - Cancer Chemotherapy.
  • MedlinePlus Health Information. consumer health - Hodgkin Disease.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Am J Pathol. 1997 Mar;150(3):793-803 [9060817.001]
  • [Cites] J Clin Oncol. 1994 Feb;12(2):312-25 [8113838.001]
  • [Cites] J Clin Oncol. 1998 Jan;16(1):338-47 [9440762.001]
  • [Cites] Ann Oncol. 1991 Feb;2 Suppl 2:83-92 [2049324.001]
  • [Cites] Ann Oncol. 1992 Sep;3 Suppl 4:35-8 [1450078.001]
  • [Cites] J Clin Oncol. 2002 Aug 15;20(16):3484-94 [12177110.001]
  • [Cites] J Clin Oncol. 2003 Sep 15;21(18):3440-6 [12668650.001]
  • [Cites] Ann Oncol. 2004 Jul;15(7):1079-85 [15205202.001]
  • [Cites] Blood. 2003 May 15;101(10):4063-9 [12543871.001]
  • [Cites] J Clin Oncol. 1989 Aug;7(8):1046-58 [2754447.001]
  • [Cites] Ann Oncol. 1996;7 Suppl 4:115-26 [8836422.001]
  • [Cites] Crit Rev Oncol Hematol. 2005 Nov;56(2):235-45 [16207531.001]
  • [Cites] J Clin Oncol. 2002 Apr 15;20(8):2101-8 [11956271.001]
  • [Cites] Am J Pathol. 1997 Oct;151(4):1123-30 [9327746.001]
  • [Cites] Ann Oncol. 2004 Feb;15(2):276-82 [14760122.001]
  • [Cites] J Clin Oncol. 2000 Feb;18(3):498-509 [10653865.001]
  • [Cites] Lancet. 1997 Feb 1;349(9048):344-9 [9024390.001]
  • [Cites] JAMA. 1990 Aug 22-29;264(8):1006-8 [2376872.001]
  • [Cites] Curr Opin Oncol. 1993 Sep;5(5):805-11 [8218492.001]
  • [Cites] N Engl J Med. 1992 Nov 19;327(21):1478-84 [1383821.001]
  • [Cites] N Engl J Med. 1988 Jan 14;318(2):76-81 [3336397.001]
  • [Cites] Leuk Lymphoma. 1996 Jan;20(3-4):297-301 [8624470.001]
  • [Cites] Ann Hematol. 1999 Dec;78(12):544-54 [10647878.001]
  • [Cites] Ann Oncol. 1996 Aug;7(6):555-60 [8879367.001]
  • [Cites] Blood. 2000 Feb 15;95(4):1207-13 [10666192.001]
  • [Cites] J Clin Oncol. 1993 Feb;11(2):255-61 [8426202.001]
  • [Cites] J Clin Oncol. 2000 Mar;18(5):972-80 [10694546.001]
  • [Cites] J Clin Oncol. 2000 Feb;18(3):487-97 [10653864.001]
  • [Cites] N Engl J Med. 1990 Jan 4;322(1):7-13 [2403650.001]
  • [Cites] J Clin Oncol. 2003 Sep 15;21(18):3431-9 [12885835.001]
  • [Cites] J Clin Oncol. 2000 Jun;18(12):2435-43 [10856104.001]
  • [Cites] J Clin Oncol. 2001 Apr 1;19(7):2026-32 [11310450.001]
  • [Cites] Ann Oncol. 1992 Sep;3 Suppl 4:117-28 [1450072.001]
  • [Cites] J Natl Cancer Inst. 2002 Feb 6;94(3):182-92 [11830608.001]
  • (PMID = 16369761.001).
  • [ISSN] 0172-8113
  • [Journal-full-title] Der Pathologe
  • [ISO-abbreviation] Pathologe
  • [Language] ger
  • [Publication-type] English Abstract; Journal Article
  • [Publication-country] Germany
  • [Chemical-registry-number] 0 / Antineoplastic Agents
  •  go-up   go-down


86. Klein F: [Non-small-cell bronchial carcinoma--prognostic value of IGF protein]. Pneumologie; 2007 Oct;61(10):625
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Non-small-cell bronchial carcinoma--prognostic value of IGF protein].
  • [Transliterated title] Nichtkleinzelliges Bronchialkarzinom--Prognostischer Wert von IGF-Proteinen.
  • [MeSH-major] Biomarkers, Tumor / blood. Bronchial Neoplasms / diagnosis. Carcinoma, Non-Small-Cell Lung / diagnosis. Insulin-Like Growth Factor Binding Protein 3 / blood. Insulin-Like Growth Factor I / metabolism. Insulin-Like Growth Factor II / metabolism
  • [MeSH-minor] Adult. Aged. Clinical Trials as Topic. Disease-Free Survival. Female. Hormones / metabolism. Humans. Male. Middle Aged. Neoplasm Staging. Prognosis. Smoking. Survival Rate

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17922382.001).
  • [ISSN] 1438-8790
  • [Journal-full-title] Pneumologie (Stuttgart, Germany)
  • [ISO-abbreviation] Pneumologie
  • [Language] ger
  • [Publication-type] Journal Article
  • [Publication-country] Germany
  • [Chemical-registry-number] 0 / Biomarkers, Tumor; 0 / Hormones; 0 / Insulin-Like Growth Factor Binding Protein 3; 67763-96-6 / Insulin-Like Growth Factor I; 67763-97-7 / Insulin-Like Growth Factor II
  •  go-up   go-down


87. Centers for Disease Control and Prevention (CDC): Use of mammograms among women aged &gt; or = 40 years--United States, 2000-2005. MMWR Morb Mortal Wkly Rep; 2007 Jan 26;56(3):49-51
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Breast cancer is the most commonly diagnosed cancer and the second leading cause of cancer-related death (after lung and bronchial cancer) among women in the United States.
  • In 2002, at least 182,125 women in the United States had a diagnosis of invasive breast cancer, and 41,514 died from the disease.
  • Screening mammography can reduce mortality from breast cancer by approximately 20%-35% in women aged 50-69 years and approximately 20% in women aged 40-49 years.
  • Organizations including the American Medical Association, American College of Obstetricians and Gynecologists, and American Cancer Society support mammography screening beginning at age 40 years, although these groups vary in their recommendations regarding intervals for rescreening.
  • The U.S. Preventive Services Task Force, an independent panel of private-sector experts in prevention and primary care convened by the Department of Health and Human Services, recommends that women aged < or = 40 years be screened for breast cancer with a mammogram every 1-2 years.
  • Continued declines in mammography use might result in increased breast cancer mortality.

  • MedlinePlus Health Information. consumer health - Mammography.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17251897.001).
  • [ISSN] 1545-861X
  • [Journal-full-title] MMWR. Morbidity and mortality weekly report
  • [ISO-abbreviation] MMWR Morb. Mortal. Wkly. Rep.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  •  go-up   go-down


88. Balga I, Gerber H, Konrad C, Diebold J: [Development of a soft tissue ulcer after long-term peridural infusion]. Anaesthesist; 2009 Feb;58(2):156-62
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • The case of a 74-year-old female patient (BMI 16.8 kg/m(2)) with a metastasising bronchial carcinoma is reported, who suffered from severe back pain due to tumour infiltration.
  • [MeSH-minor] Aged. Analgesics, Opioid / administration & dosage. Analgesics, Opioid / therapeutic use. Anesthetics, Local / administration & dosage. Anesthetics, Local / therapeutic use. Bronchial Neoplasms / complications. Bronchial Neoplasms / surgery. Bupivacaine / administration & dosage. Bupivacaine / therapeutic use. Epidural Space / pathology. Female. Humans. Long-Term Care. Morphine / administration & dosage. Morphine / therapeutic use. Pain / complications. Pain / drug therapy. Staphylococcal Infections / etiology. Staphylococcal Infections / microbiology. Staphylococcal Infections / pathology. Tomography, X-Ray Computed

  • Hazardous Substances Data Bank. MORPHINE .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Ophthalmology. 1992 Apr;99(4):582-9 [1584577.001]
  • [Cites] Anaesthesist. 2007 May;56(5):499-523; quiz 524-6 [17431551.001]
  • [Cites] Acta Neuropathol. 1983;60(3-4):167-74 [6613529.001]
  • [Cites] Anesth Analg. 1981 Jul;60(7):471-80 [7195662.001]
  • [Cites] Anaesthesist. 1998 Jul;47(7):605-9 [9740936.001]
  • [Cites] J Orthop Res. 1990 Jul;8(4):485-94 [2355288.001]
  • [Cites] Anaesthesist. 2007 Feb;56(2):118-27 [17235544.001]
  • [Cites] Arch Ophthalmol. 1985 Sep;103(9):1373-7 [4038130.001]
  • [Cites] J Orthop Res. 1990 Jul;8(4):495-503 [2355289.001]
  • [Cites] Klin Monbl Augenheilkd. 1994 Mar;204(3):176-80 [8196304.001]
  • [Cites] Anat Rec. 1978 Jul;191(3):351-69 [677489.001]
  • [Cites] Anesth Analg. 2003 Oct;97(4):1173-9, table of contents [14500177.001]
  • [Cites] Reg Anesth Pain Med. 2004 Jul-Aug;29(4):333-40 [15305253.001]
  • [Cites] Anesth Analg. 1980 Oct;59(10):727-36 [7191645.001]
  • [Cites] Anesthesiology. 1988 Aug;69(2):289 [3407988.001]
  • [Cites] Anesthesiology. 1994 Apr;80(4):942-7 [8024149.001]
  • [Cites] J Anat. 1970 Nov;107(Pt 3):547-56 [5492943.001]
  • [Cites] J Pain Symptom Manage. 1994 Jul;9(5):308-11 [7963782.001]
  • [Cites] Anaesthesist. 2003 Dec;52(12):1102-23 [14691623.001]
  • [Cites] Anesth Analg. 2005 Aug;101(2):548-54, table of contents [16037174.001]
  • [Cites] Anesthesiology. 1999 Mar;90(3):835-43 [10078686.001]
  • [Cites] Br J Anaesth. 2004 Jun;92(6):899-901 [15096444.001]
  • [Cites] Acta Anaesthesiol Scand. 1986 Nov;30(8):625-9 [3811805.001]
  • [Cites] J Biol Chem. 2002 Apr 5;277(14):12221-7 [11790774.001]
  • [Cites] J Pain Symptom Manage. 2004 Dec;28(6):603-11 [15589086.001]
  • [Cites] Anesthesiology. 2002 Sep;97(3):710-6 [12218539.001]
  • [Cites] Br J Exp Pathol. 1980 Apr;61(2):139-49 [7426373.001]
  • [Cites] J Oral Surg. 1978 Jul;36(7):530-3 [277638.001]
  • [Cites] Anesthesiology. 2007 May;106(5):1026-34 [17457136.001]
  • [Cites] Anesthesiology. 2005 Apr;102(4):793-8 [15791109.001]
  • [Cites] Neurochem Res. 2001 Jul;26(7):841-4 [11565617.001]
  • (PMID = 18958432.001).
  • [ISSN] 1432-055X
  • [Journal-full-title] Der Anaesthesist
  • [ISO-abbreviation] Anaesthesist
  • [Language] ger
  • [Publication-type] Case Reports; English Abstract; Journal Article
  • [Publication-country] Germany
  • [Chemical-registry-number] 0 / Analgesics, Opioid; 0 / Anesthetics, Local; 76I7G6D29C / Morphine; Y8335394RO / Bupivacaine
  •  go-up   go-down


89. Westeel V: [Follow up of non small cell lung cancer. Should patients be followed up after surgery for non-small cell lung cancer and how?]. Rev Mal Respir; 2006 Nov;23(5 Pt 3):16S84-16S87
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Follow up of non small cell lung cancer. Should patients be followed up after surgery for non-small cell lung cancer and how?].
  • [Transliterated title] Surveillance des CBNPC. Faut-il surveiller les patients opérés d'un carcinome bronchique non à petites cellules et comment?
  • INTRODUCTION: Survival of patients after surgery for non-small cell lung cancer is significantly impaired because of frequent fatal recurrences.
  • These data show that: thoracic recurrences are the most frequent and the most frequently treated with curative intent; diagnosis of recurrences while patients are still asymptomatic might improve survival.
  • Only one randomized trial is ongoing, conducted by the Intergroupe Francophone de Cancérologie Thoracique (IFCT).
  • As it is not possible to define the optimal follow-up after surgery for non-small cell lung cancer from existing data, the IFCT randomized study represents for pulmonologists, oncologists and thoracic surgeons a good opportunity to rationalize postoperative follow-up.
  • [MeSH-major] Carcinoma, Non-Small-Cell Lung / surgery. Lung Neoplasms / surgery

  • Genetic Alliance. consumer health - Lung Cancer.
  • Genetic Alliance. consumer health - Non-small cell lung cancer.
  • MedlinePlus Health Information. consumer health - Lung Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17268342.001).
  • [ISSN] 0761-8425
  • [Journal-full-title] Revue des maladies respiratoires
  • [ISO-abbreviation] Rev Mal Respir
  • [Language] fre
  • [Publication-type] English Abstract; Journal Article; Review
  • [Publication-country] France
  • [Number-of-references] 21
  •  go-up   go-down


90. Pérol M: [The place of targeted therapies in the management of non-small cell bronchial carcinoma. Methodology of the development of targeted therapies in pulmonary oncology]. Rev Mal Respir; 2006 Nov;23(5 Pt 3):16S148-16S157
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [The place of targeted therapies in the management of non-small cell bronchial carcinoma. Methodology of the development of targeted therapies in pulmonary oncology].
  • [Transliterated title] La place des thérapeutiques ciblées dans la prise en charge des CBNPC. Méthodologie du développement des thérapeutiques ciblées en cancérologie pulmonaire.
  • The development of new anticancer agents specifically targeting the molecular processes involved in carcinogenesis is a major step forward in the treatment of patients with lung cancer.
  • [MeSH-major] Carcinoma, Bronchogenic / drug therapy. Carcinoma, Non-Small-Cell Lung / drug therapy. Lung Neoplasms / drug therapy

  • MedlinePlus Health Information. consumer health - Lung Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17268352.001).
  • [ISSN] 0761-8425
  • [Journal-full-title] Revue des maladies respiratoires
  • [ISO-abbreviation] Rev Mal Respir
  • [Language] fre
  • [Publication-type] English Abstract; Journal Article; Review
  • [Publication-country] France
  • [Number-of-references] 26
  •  go-up   go-down


91. Padilla J, Peñalver JC, Jordá C, Calvo V, Escrivá J, Cerón J, García Zarza A, Pastor J, Blasco E: [Non-small cell bronchogenic cancer in stage IA: mortality patterns after surgery]. Arch Bronconeumol; 2005 Apr;41(4):180-4
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Non-small cell bronchogenic cancer in stage IA: mortality patterns after surgery].
  • [Transliterated title] Carcinoma broncogénico no anaplásico de células pequeñas en estadio IA. Cirugía y patrones de mortalidad.
  • OBJECTIVE: To determine the causes of death in patients treated surgically for nonsmall cell lung cancer (NSCLC) in stage IA and to evaluate the impact on survival of not performing systematic lymph node dissection and of the number of nodes resected.
  • The cause of death was unrelated to NSCLC in 62 (39.7%) cases: 33 (21.1%) had a new tumor, 18 of which were bronchogenic, and 29 (18.5%) had nonmalignant disease.
  • [MeSH-major] Carcinoma, Bronchogenic / mortality. Carcinoma, Non-Small-Cell Lung / mortality. Lung Neoplasms / mortality
  • [MeSH-minor] Adult. Aged. Aged, 80 and over. Cause of Death. Female. Humans. Lymph Node Excision. Male. Middle Aged. Neoplasm Staging. Survival Rate

  • MedlinePlus Health Information. consumer health - Lung Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [CommentIn] Arch Bronconeumol. 2005 Apr;41(4):177-9 [15826525.001]
  • (PMID = 15826526.001).
  • [ISSN] 0300-2896
  • [Journal-full-title] Archivos de bronconeumología
  • [ISO-abbreviation] Arch. Bronconeumol.
  • [Language] spa
  • [Publication-type] English Abstract; Journal Article
  • [Publication-country] Spain
  •  go-up   go-down


92. Rea F, Marulli G, Schiavon M, Zuin A, Hamad AM, Feltracco P, Sartori F: Tracheal sleeve pneumonectomy for non small cell lung cancer (NSCLC): short and long-term results in a single institution. Lung Cancer; 2008 Aug;61(2):202-8
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Tracheal sleeve pneumonectomy for non small cell lung cancer (NSCLC): short and long-term results in a single institution.
  • OBJECTIVE: Bronchogenic carcinoma involving the carina or tracheobronchial angle still presents a challenge due to specific problems related to surgical technique and airway management.
  • Histology was squamous cell carcinoma in 38 (77.6%) cases, adenocarcinoma in 10 (20.4%), and large-cell carcinoma in 1 (2%).
  • CONCLUSIONS: Tracheal sleeve pneumonectomy for bronchogenic carcinoma can be accomplished with acceptable mortality and morbidity, providing good long-term results.
  • [MeSH-major] Arrhythmias, Cardiac / mortality. Carcinoma, Non-Small-Cell Lung / surgery. Lung Neoplasms / surgery. Pneumonectomy. Postoperative Complications / mortality. Trachea / surgery


93. Congregado M, Merchan RJ, Gallardo G, Ayarra J, Loscertales J: Video-assisted thoracic surgery (VATS) lobectomy: 13 years' experience. Surg Endosc; 2008 Aug;22(8):1852-7
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • BACKGROUND: Major lung resection by video-assisted thoracic surgery (VATS) has been proven to be both safe and technically feasible, but is not routinely performed in most hospitals.
  • The clinical records of all patients were drawn from the hospital archive and data for the following variables were recorded for analysis: age, sex, clinical diagnosis, clinical status, date of surgery, type of surgery, inoperability, conversion to conventional surgery and reasons, duration of surgery and intraoperative complications, postoperative and long-term complications, postoperative stay, diagnosis, definitive status, and mortality.
  • RESULTS: A total of 237 major pulmonary resections were performed, on 203 males and 34 males, with a mean age of 61.43 years (non-small-cell bronchogenic carcinoma: 204, benign processes: 24, carcinoid tumors: 4, and lobectomy due to metastases: 5).
  • CONCLUSIONS: VATS lobectomy is a viable safe procedure that meets oncological criteria for lung cancer surgery.
  • In our experience, VATS is currently to be considered ideally indicated for certain benign processes and for T1-T2 N0 M0 bronchogenic carcinomas.
  • [MeSH-major] Lung / surgery. Thoracic Surgery, Video-Assisted
  • [MeSH-minor] Adolescent. Adult. Aged. Carcinoid Tumor / surgery. Carcinoma, Bronchogenic / surgery. Child. Female. Follow-Up Studies. Humans. Length of Stay. Lung Diseases / surgery. Lung Neoplasms / pathology. Lung Neoplasms / surgery. Male. Middle Aged. Neoplasm Metastasis. Neoplasm Recurrence, Local. Neoplasm Staging. Pneumonectomy / adverse effects. Retrospective Studies. Survival Analysis. Time Factors

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Semin Thorac Cardiovasc Surg. 1998 Oct;10(4):291-9 [9801250.001]
  • [Cites] Ann Thorac Surg. 2002 Mar;73(3):900-4 [11899198.001]
  • [Cites] Ann Thorac Surg. 2000 Jul;70(1):243-7 [10921716.001]
  • [Cites] Ann Ital Chir. 2000 Sep-Oct;71(5):539-43 [11217470.001]
  • [Cites] Eur J Cardiothorac Surg. 2001 Sep;20(3):455-63 [11509263.001]
  • [Cites] J Pediatr Surg. 2003 Jan;38(1):102-4 [12592629.001]
  • [Cites] Surg Today. 2003;33(1):7-12 [12560900.001]
  • [Cites] Ann Thorac Surg. 2006 Feb;81(2):421-5; discussion 425-6 [16427825.001]
  • [Cites] Ann Thorac Surg. 2001 Aug;72(2):362-5 [11515867.001]
  • [Cites] Eur J Cardiothorac Surg. 2004 Jul;26(1):158-64 [15200996.001]
  • [Cites] Eur J Cardiothorac Surg. 2006 Jun;29(6):997-1000 [16716918.001]
  • [Cites] Surg Endosc. 2003 Apr;17(4):632-5 [12582766.001]
  • [Cites] Chest. 1996 Jun;109(6):1636-42 [8769523.001]
  • [Cites] Ann Ital Chir. 2003 May-Jun;74(3):299-307 [14677287.001]
  • [Cites] Eur J Cardiothorac Surg. 2000 Jul;18(1):7-11 [10869933.001]
  • [Cites] World J Surg. 2000 Jan;24(1):27-30; discussion 30-1 [10594199.001]
  • [Cites] Eur J Cardiothorac Surg. 2006 May;29(5):806-9 [16581257.001]
  • [Cites] Semin Thorac Cardiovasc Surg. 1998 Oct;10(4):285-90 [9801249.001]
  • [Cites] Ann Thorac Surg. 2003 Oct;76(4):1009-14; discussion 1014-5 [14529976.001]
  • [Cites] Chest. 2004 Sep;126(3):725-32 [15364748.001]
  • [Cites] Surg Endosc. 2002 Jun;16(6):881-92 [12163949.001]
  • [Cites] Ann Thorac Surg. 2000 Nov;70(5):1644-6 [11093502.001]
  • [Cites] Eur J Cardiothorac Surg. 2001 Sep;20(3):437-42 [11509260.001]
  • [Cites] Thorac Cardiovasc Surg. 2006 Apr;54(3):202-7 [16639684.001]
  • [Cites] Eur J Cardiothorac Surg. 2003 Mar;23(3):397-402 [12614813.001]
  • (PMID = 18157567.001).
  • [ISSN] 1432-2218
  • [Journal-full-title] Surgical endoscopy
  • [ISO-abbreviation] Surg Endosc
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] Germany
  •  go-up   go-down


94. McCaughan F, Darai-Ramqvist E, Bankier AT, Konfortov BA, Foster N, George PJ, Rabbitts TH, Kost-Alimova M, Rabbitts PH, Dear PH: Microdissection molecular copy-number counting (microMCC)--unlocking cancer archives with digital PCR. J Pathol; 2008 Nov;216(3):307-16
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Microdissection molecular copy-number counting (microMCC)--unlocking cancer archives with digital PCR.
  • Most cancer genomes are characterized by the gain or loss of copies of some sequences through deletion, amplification or unbalanced translocations.
  • Delineating and quantifying these changes is important in understanding the initiation and progression of cancer, in identifying novel therapeutic targets, and in the diagnosis and prognosis of individual patients.
  • Molecular copy-number counting (MCC), a digital PCR technique, has been used to delineate a non-reciprocal translocation using good quality DNA from a renal carcinoma cell line.
  • Finally, we demonstrate the power of microMCC to precisely interrogate cancer genomes, in a way not currently feasible with other methodologies, by defining the position of a junction between an amplified and non-amplified genomic segment in a bronchial carcinoma.
  • This has tremendous potential for the exploitation of archived resources for high-resolution targeted cancer genomics and in the future for interrogating multiple loci in cancer diagnostics or prognostics.
  • [MeSH-major] DNA, Neoplasm / genetics. Gene Dosage. Neoplasms / genetics. Polymerase Chain Reaction / methods
  • [MeSH-minor] Carcinoma, Bronchogenic / genetics. DNA Primers / genetics. Gene Amplification. Genetic Markers. Genome, Human. Humans. Lung Neoplasms / genetics. Microdissection. Paraffin Embedding. Tissue Fixation

  • The Lens. Cited by Patents in .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] (c) 2008 Pathological Society of Great Britain and Ireland. Published by John Wiley & Sons, Ltd.
  • (PMID = 18773450.001).
  • [ISSN] 1096-9896
  • [Journal-full-title] The Journal of pathology
  • [ISO-abbreviation] J. Pathol.
  • [Language] eng
  • [Grant] United Kingdom / Medical Research Council / / MC/ U105131672; United Kingdom / Medical Research Council / / ; United Kingdom / Medical Research Council / / G0600914; United Kingdom / Medical Research Council / / G0500392; United Kingdom / Medical Research Council / / MC/ U105178807
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] England
  • [Chemical-registry-number] 0 / DNA Primers; 0 / DNA, Neoplasm; 0 / Genetic Markers
  •  go-up   go-down


95. Agrawal NN, Ghogare MS, Bansod YV: Unusual presentation of bronchogenic carcinoma. J Assoc Physicians India; 2009 Jan;57:84-6
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Unusual presentation of bronchogenic carcinoma.
  • [MeSH-major] Bone Neoplasms / secondary. Carcinoma, Bronchogenic / diagnosis. Lung Neoplasms / diagnosis

  • MedlinePlus Health Information. consumer health - Bone Cancer.
  • MedlinePlus Health Information. consumer health - Lung Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19753769.001).
  • [ISSN] 0004-5772
  • [Journal-full-title] The Journal of the Association of Physicians of India
  • [ISO-abbreviation] J Assoc Physicians India
  • [Language] eng
  • [Publication-type] Case Reports; Letter
  • [Publication-country] India
  •  go-up   go-down


96. Camargo Jde J, Machuca TN, Camargo SM, Schio SM, Bello RM: Synchronous pulmonary and hepatic nodules in a patient with previous bronchogenic carcinoma: the relevance of histopathological confirmation. J Bras Pneumol; 2009 Jun;35(6):602-5
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Synchronous pulmonary and hepatic nodules in a patient with previous bronchogenic carcinoma: the relevance of histopathological confirmation.
  • The synchronous presentation of pulmonary and hepatic nodules in a patient with previously resected bronchogenic carcinoma raises suspicion of recurrence and mandates restaging.
  • Despite the strong suspicion of tumor recurrence, further investigation with a percutaneous liver biopsy revealed hepatocellular carcinoma.
  • In order to investigate the etiology of the pulmonary lesion (hypotheses of recurrent bronchial cancer and of metastatic hepatocellular carcinoma), an open lung biopsy was performed, which revealed chronic inflammatory tissue with foci of anthracosis and dystrophic calcification.
  • This report highlights the relevance of the histopathological diagnosis in patients with a history of bronchogenic carcinoma and suspicion of tumor recurrence.
  • [MeSH-major] Calcinosis / complications. Carcinoma, Hepatocellular / complications. Liver Neoplasms / complications. Lung Diseases / complications
  • [MeSH-minor] Aged. Biopsy. Carcinoma, Bronchogenic / surgery. Humans. Lung Neoplasms / surgery. Male. Neoplasm Staging. Tomography, X-Ray Computed

  • MedlinePlus Health Information. consumer health - Liver Cancer.
  • MedlinePlus Health Information. consumer health - Lung Diseases.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19618039.001).
  • [ISSN] 1806-3756
  • [Journal-full-title] Jornal brasileiro de pneumologia : publicaça̋o oficial da Sociedade Brasileira de Pneumologia e Tisilogia
  • [ISO-abbreviation] J Bras Pneumol
  • [Language] eng; por
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] Brazil
  •  go-up   go-down


97. Bartsch V: [Oral vinorelbine: pharmacology and treatment outcome in non-small cell bronchial carcinoma and breast carcinoma]. Onkologie; 2006 Mar;29 Suppl 1:1-28
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Oral vinorelbine: pharmacology and treatment outcome in non-small cell bronchial carcinoma and breast carcinoma].
  • [Transliterated title] Orales Vinorelbin: Pharmakologie und Behandlungsergebnisse beim nichtkleinzelligen Bronchialkarzinom und Mammakarzinom.
  • The development of an oral formulation of vinorelbine (Navelbine softgelatine capsules, Pierre Fabre Pharma, Freiburg i.Br., Germany) represents a significant advance in the treatment of patients with cancer.
  • Several clinical studies have demonstrated that the new oral formulation of vinorelbine can be safely administered, even to elderly patients, and is comparable in activity to intravenous vinorelbine in advanced non-small cell lung cancer (NSCLC) and metastatic breast cancer (MBC).
  • [MeSH-major] Antineoplastic Agents, Phytogenic / administration & dosage. Breast Neoplasms / drug therapy. Carcinoma, Non-Small-Cell Lung / drug therapy. Lung Neoplasms / drug therapy. Vinblastine / analogs & derivatives
  • [MeSH-minor] Administration, Oral. Antineoplastic Combined Chemotherapy Protocols / adverse effects. Antineoplastic Combined Chemotherapy Protocols / pharmacokinetics. Antineoplastic Combined Chemotherapy Protocols / therapeutic use. Biological Availability. Chemotherapy, Adjuvant. Clinical Trials as Topic. Dose-Response Relationship, Drug. Drug Administration Schedule. Female. Humans. Infusions, Intravenous. Neoplasm Staging. Survival Rate. Treatment Outcome

  • MedlinePlus Health Information. consumer health - Breast Cancer.
  • MedlinePlus Health Information. consumer health - Lung Cancer.
  • Hazardous Substances Data Bank. VINORELBINE .
  • Hazardous Substances Data Bank. VINBLASTINE .
  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16534241.001).
  • [ISSN] 0378-584X
  • [Journal-full-title] Onkologie
  • [ISO-abbreviation] Onkologie
  • [Language] ger
  • [Publication-type] Comparative Study; English Abstract; Journal Article; Review
  • [Publication-country] Switzerland
  • [Chemical-registry-number] 0 / Antineoplastic Agents, Phytogenic; 5V9KLZ54CY / Vinblastine; Q6C979R91Y / vinorelbine
  • [Number-of-references] 83
  •  go-up   go-down


98. Blackhall F, Papakotoulas PI, Danson S, Thatcher N: Perspectives on novel therapies for bronchial carcinoma. Expert Opin Pharmacother; 2005 Jun;6(7):1157-67
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Perspectives on novel therapies for bronchial carcinoma.
  • Improvements in conventional cytotoxic treatment have probably reached a plateau for the treatment of lung cancer; therefore, new treatment strategies that are based on a better understanding of tumour biology are required.
  • Some progress has been made for non-small cell lung cancer, in which erlotinib (Tarceva, OSI-774; Genentech), an epidermal growth factor receptor antagonist, has demonstrated a significant clinical benefit in a Phase III randomised trial, and has been licensed for second- or third-line treatment.
  • In this article the recent and ongoing Phase II and III trials of these therapies in lung cancer are summarised, and the prospects for their further clinical development are discussed.
  • [MeSH-major] Antineoplastic Agents / therapeutic use. Carcinoma, Bronchogenic / drug therapy. Carcinoma, Small Cell / drug therapy. Lung Neoplasms / drug therapy

  • MedlinePlus Health Information. consumer health - Cancer Chemotherapy.
  • MedlinePlus Health Information. consumer health - Lung Cancer.
  • Hazardous Substances Data Bank. CELECOXIB .
  • NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 15957969.001).
  • [ISSN] 1744-7666
  • [Journal-full-title] Expert opinion on pharmacotherapy
  • [ISO-abbreviation] Expert Opin Pharmacother
  • [Language] eng
  • [Publication-type] Journal Article; Review
  • [Publication-country] England
  • [Chemical-registry-number] 0 / Angiogenesis Inhibitors; 0 / Antibodies, Monoclonal; 0 / Antibodies, Monoclonal, Humanized; 0 / Antineoplastic Agents; 0 / Cyclooxygenase 2 Inhibitors; 0 / Protein Kinase Inhibitors; 0 / Pyrazoles; 0 / Quinazolines; 0 / Sulfonamides; 0 / Vascular Endothelial Growth Factor A; 2S9ZZM9Q9V / Bevacizumab; DA87705X9K / Erlotinib Hydrochloride; EC 2.7.10.1 / Receptor, Epidermal Growth Factor; JCX84Q7J1L / Celecoxib
  • [Number-of-references] 65
  •  go-up   go-down


99. Bugajna K, Lewczuk J, Piszko P, Lenartowska L, Nowak M, Ludwig B, Prajs P, Wrabec K: [Bronchial adenocarcinoma mimicking acute pulmonary embolism -- a case report]. Kardiol Pol; 2005 Dec;63(6):652-5
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Bronchial adenocarcinoma mimicking acute pulmonary embolism -- a case report].
  • [Transliterated title] Gruczołowy rak oskrzelikowy naśladujacy ostra zatorowość płucna.
  • A case of a 31-year-old male with medical history, clinical symptoms and additional diagnostic tests strongly suggesting diagnosis of acute pulmonary embolism is presented.
  • At autopsy bronchial carcinoma was found and this definitive diagnosis was confirmed by the results of histopathological study.
  • [MeSH-major] Adenocarcinoma / pathology. Bronchial Neoplasms / pathology. Pulmonary Embolism / pathology
  • [MeSH-minor] Adult. Autopsy. Diagnosis, Differential. Fatal Outcome. Humans. Male

  • Genetic Alliance. consumer health - Embolism.
  • MedlinePlus Health Information. consumer health - Pulmonary Embolism.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16380871.001).
  • [ISSN] 0022-9032
  • [Journal-full-title] Kardiologia polska
  • [ISO-abbreviation] Kardiol Pol
  • [Language] pol
  • [Publication-type] Case Reports; English Abstract; Journal Article
  • [Publication-country] Poland
  •  go-up   go-down


100. Kim HJ, Kim MJ, Lee MJ, Ahn JH, Kim HS, Kim IS, Lee JS, Lee GW: Coexistence of chronic myeloid leukemia and pulmonary plasmacytoma mimicking primary lung cancer. Int J Hematol; 2010 Nov;92(4):651-4
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Coexistence of chronic myeloid leukemia and pulmonary plasmacytoma mimicking primary lung cancer.
  • A 61-year-old man was diagnosed with the simultaneous occurrence of chronic myeloid leukemia (CML) and infiltrative intrathoracic plasmacytoma, radiologically mimicking bronchogenic carcinoma.
  • [MeSH-major] Leukemia, Myeloid, Chronic-Phase / diagnosis. Neoplasms, Multiple Primary / diagnosis. Plasmacytoma / diagnosis. Thoracic Neoplasms / diagnosis
  • [MeSH-minor] Carcinoma, Bronchogenic / diagnosis. Diagnosis, Differential. Fatal Outcome. Humans. Lung Neoplasms / diagnosis. Male. Middle Aged






Advertisement